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Atypical EAE represents an extension of the classical EAE model since in multiple sclerosis (MS), a
human disease often modeled by EAE, inflammatory foci could be found in both the spinal cord and
different brain regions. Although no consensus exists on the mechanisms that lead to the occurrence of
atypical EAE, there is an understanding that the inability of the invading T cells to produce IFN￿ leads
to their particular cytokine and chemokine receptor expression profile that results in their differential
homing and a distinct pattern of tissue damage to the CNS. Multiple studies have also suggested that
IL17A is indispensable for the occurrence of atypical EAE. Our work supports a different view, where
the inability of a particular cell type (either of the invaded tissue or among the invading cells themselves)
to sense IFN￿ is the key event that eventually leads to the occurrence of atypical EAE. We show that
various mouse strains lacking IFN￿ or the functional IFN￿ receptor are all susceptible to the induction
of atypical EAE and IL17A is completely dispensable for this process. The disrupted IFN￿ signaling in
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Ab   antibody 
Ag  antigen 
APC   antigen presenting cell 
AT EAE  Adoptive transfer experimental autoimmune encephalomyelitis 
BBB  blood brain barrier 
BM  bone marrow 
BMC  bone marrow chimera 
bp   base pair  
BSA   bovine serum albumin 
CCL  chemokine ligand 
CCR  chemokine receptor 
CD   cluster of differentiation 
CFA   Complete Freund’s Adjuvant 
CNS   central nervous system 
Cre   LoxP site-specific recombinase  
CSF  Cerebrospinal Fluid 
CTL  cytotoxic T lymphocyte 
DAMP Danger-associated molecular pattern(s) 
DC   dendritic cell 
DNA   desoxyribonucleic acid 
dNTP   desoxynucleotide triphosphate 
EAE   experimental autoimmune encephalomyelitis 
EDTA  ethylene-diaminetetraacetic acid 
EYFP  Enhanced Yellow Fluorescent Protein  
FACS   fluorescence-activated cell sorting 
FCS   fetal calf serum 
flox(ed) LoxP flanked 
FoxP3  forkhead box protein 3 
GM-CSF granulocyte/macrophage-colony stimulating factor 
HE  Hematoxylin/Eosin stain 
HEPES  N-2-hydroxyethylpiperazine-N’-2-ethansulfonic acid 
HLA  human leukocyte antigen 
ICAM-1 intercellular adhesion molecule 1 
i.p.   intraperitoneally 
 i.v.   intravenously 
IFN-γ   interferon-γ 
Ig   immunoglobulin 
IL   interleukin 
IRES  internal ribosome entry site 
LFB-PAS Luxol Fast Blue-Periodic Acid-Schiff stain 
LN   lymph node/s 
loxP   recognition sequence for Cre 
LPS   lipopolysaccharide 
mAb  monoclonal antibody 
MBP  myelin basic protein 
MCP-1 Macrophage chemoattractant protein-1 
MHC   major histocompatibility complex 
MIP-2  Macrophage inflammatory protein 2 
moDC  monocyte-derived dendritic cell 
MOG   myelin oligodendrocyte glycoprotein 
MS   multiple sclerosis 
PAMP Pathogen-associated molecular pattern(s) 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
pDC  plasmacytoid dendritic cell 
PNS  peripheral nervous system 
PRR  Pattern recognition receptor 
Ptx   Pertussis toxin 
RAG   recombination activating gene 
RNA   ribonucleic acid 
RRMS  Relapsing-remitting multiple sclerosis 
s.c.   subcutaneously 
SLO  secondary lymphoid organs 
Taq   polymerase from Thermus aquaticus 
TCA-3 T cell activation gene 3 
TCR   T cell receptor 
TE   Tris-EDTA buffer 
tg   transgenic 
TLR  toll-like receptor 
Tregs   regulatory T cells 
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Aim of the thesis 
Clinical studies of MS showed that patients with affected cerebella 
displayed rapid disease progression and had poor prognosis. At the same time, 
therapeutic approaches that interfered with the trafficking of activated immune 
cells had shown promising results. 
The main aim of the thesis was to use a mouse model of atypical EAE in 
the context of IFNγ deficiency and test the hypothesis that there exists a single 
cell type which, when prevented in sensing IFNγ during the initiating phase of 
EAE, institutes a series of events that eventually lead to a deep parenchymal 
infiltration of immune cells into the brain instead to the usual site, the spinal 
cord, resulting in an extensive tissue destruction at the site. 
If proven correct, the implicated cell type and its interactions with the 
invaded CNS tissue and immune cells were to be investigated in greater detail in 
an effort to establish the mechanism of action that underlies these decisive early 
events of EAE. 
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Summary 
Experimental autoimmune encephalomyelitis (EAE) is a robust and 
valuable animal model of autoimmune inflammation of the central nervous 
system (CNS). Clinically, in most rodents, it presents itself as an ascending 
paralysis (rostro-caudal), reflecting inflammation localized predominantly in the 
spinal cord. Variations from the classical EAE phenotype have also been 
described (referred to as atypical or nonclassical EAE) and have been shown to 
occur in certain strain- or antigen combinations and in mice deficient in 
interferon gamma (IFNγ) or its receptor. The clinical signs observed in atypical 
EAE reflect increased inflammation of the brain stem and cerebellum whereas the 
spinal cord is relatively spared. Atypical EAE represents an extension of the 
classical EAE model since in multiple sclerosis (MS), a human disease often 
modeled by EAE, inflammatory foci could be found in both the spinal cord and 
different brain regions. 
Although no consensus exists on the mechanisms that lead to the 
occurrence of atypical EAE, there is an understanding that the inability of the 
invading T cells to produce IFNγ leads to their particular cytokine and 
chemokine receptor expression profile that results in their differential homing 
and a distinct pattern of tissue damage to the CNS. Multiple studies have also 
suggested that IL17A is indispensable for the occurrence of atypical EAE. 
Our work supports a different view, where the inability of a particular cell 
type (either of the invaded tissue or among the invading cells themselves) to 
sense IFNγ is the key event that eventually leads to the occurrence of atypical 
EAE. We show that various mouse strains lacking IFNγ or the functional IFNγ 
receptor are all susceptible to the induction of atypical EAE and IL17A is 
completely dispensable for this process. The disrupted IFNγ signaling in 
neutrophils and a subset of myeloid cells alone is sufficient to drive atypical EAE. 
The composition of the immune cells infiltrating the CNS is not a determinant of 
the ensuing clinical manifestation of EAE. The development of atypical EAE in 
the context of IFNγ deficiency is not mediated by disrupted IFNγ signaling in 
microglia, as was initially suggested by some authors. Furthermore, absence of 
IFNγ signaling on vascular endothelium and presumed changes in the 
expression pattern of its adhesion molecules that result from it have no impact on 
the capacity of circulating leukocytes to extravasate and reach the CNS during 
neuroinflammation. Additionally, we were able to show that the inability of the 
CNS tissue to respond to IFNγ stimulation during neuroinflammation does not 
Vinko Tosevski 
4 
 
noticeably influence the extent of tissue damage inflicted by the infiltrating 
immune cells. 
Our ability to precisely disrupt IFNγ signaling in a defined cell population 
which results in the occurrence of atypical EAE allows us to further study the 
process and its initiating events in unprecedented detail. 
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Zusammenfassung 
Experimentelle autoimmune Enzephalomyelitis (EAE) ist ein häufig 
verwendetes, anerkanntes und robustes Mausmodell für eine selbstreaktive 
Entzündungsreaktion im Zentralnervensystem (ZNS). Diese verursacht 
normalerweise eine rostro-caudal aufsteigende Paralyse, welche durch eine 
primär im Rückenmark lokalisierte Entzündung verursacht wird. In bestimmten  
Mausstämmen sowie in Abwesenheit von Interferon gamma (IFNγ) oder dessen 
Rezeptor und durch bestimmte Antigenkombinationen wurde jedoch eine 
Abweichung von dem klassischen EAE Erscheinungsbild beschrieben. Die 
klinischen Kennzeichen dieser atypischen oder nicht-klassischen Form von EAE 
sind durch eine verstärkte Entzündung des Hirnstamms sowie des Cerebellums 
bei gleichzeitiger Abwesenheit der Entzündung im Rückenmark geprägt. EAE 
wird als Mausmodel für die humane Erkrankung Multiple Sklerose verwendet, 
welche von Entzündungsherden im Rückenmark aber auch in unterschiedlichen 
Gehirnregionen begleitet ist. Daher stellt das Modell der atypischen EAE eine 
wertvolle Erweiterung der klassischen Form dar. 
Über den genauen Mechanismus der zur Entwicklung von atypischer EAE 
führt, wurde bislang kein abschließender Konsens gefunden. Es besteht die 
Annahme, dass infiltrierende T Zellen welche einen Mangel in der IFNγ 
Produktion haben, zu einem typischen Expressionsprofil von Zytokinen und 
Chemokinrezeptoren führen welches die Rekrutierung und das Muster der 
Gewebsschädigung im ZNS beeinflusst. Zusätzlich haben verschiedene Studien 
IL17A als unabdingbar für das Auftreten von atypischer EAE beschrieben. 
Die vorliegende Arbeit argumentiert zugunsten einer neuen Sichtweise, 
wobei der Defekt eines bestimmten Zelltyps (entweder von dem Zielgewebe oder 
von den eindringen Zellen selbst) IFNγ zu detektieren und darauf zu reagieren 
als Schlüsselevent für die Entwicklung von atypischer EAE definiert wird. Wir 
konnten zeigen, dass verschiedene Mausstämme, die Defekte in IFNγ oder dem 
IFNγ Rezeptor besitzen, atypische EAE entwickeln und IL17A für diesen Prozess 
nicht notwendig ist. Spezifische Elimination des IFNγ Signalweges in 
Neutrophilen und einer Subpopulation von myeloiden Zellen war hingegen 
ausreichend um die Entwicklung atypischer EAE zu initiieren. Des weiteren 
zeigen unsere Beobachtungen, dass die Zusammensetzung der infiltrierenden 
Immunzellen nicht ausschlaggebend für die nachfolgende klinische Ausprägung 
von EAE ist. Die Entwicklung von atypischer EAE in Abwesenheit von IFNγ ist 
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nicht durch den fehlenden IFNγ Signalweg in Mikroglia bestimmt auch wenn 
dies ursprünglich von einigen Gruppen postuliert wurde. Auch das Fehlen des 
IFNγ Rezeptors im Gefäßsystem und eine möglicherweise damit verbundene 
Veränderung der Zusammensetzung der Adhäsionsmoleküle hatte keinen 
Einfluss auf das Potential  der zirkulierenden Leukozyten die Blutgefäße zu 
verlassen und während der Entzündungsreaktion in das ZNS zu gelangen. 
Zusätzlich konnten wir ausschließen, dass IFNγ sowie die Reaktion darauf im 
ZNS Gewebe selbst wichtig ist um die Gewebsschädigung durch infiltrierende 
Immunzellen zu beeinflussen. 
Die Möglichkeit den IFNγ Signalweg gezielt in einer bestimmten 
Zellpopulation auszuschalten ermöglicht uns einen detaillierten Einblick in den 
genauen Prozess und in die anfänglichen Vorgänge der Entwicklung atypischer 
EAE. 
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Introduction 
Immune system 
The immune system is a complex network of tissues, cells and molecules 
that act in concert to protect the multicellular organism from threats exerted by 
pathogens, environmental toxins and deregulated cells of the organism itself. At 
the same time, very intricate control mechanisms and elaborate partitioning of 
the different niches within the organism allow the immune system to distinguish 
between, for instance, harmful and mutualistic microorganisms or deregulated 
cells and “unusual” behavior of normal cells (changes during pregnancy). This 
ability is central to the normal functioning of the immune system. 
Although all of its components are continuously active and act 
coordinately, the immune system of higher vertebrates can be seen as operating 
at three different levels of defense – physical barriers, innate immune system and 
adaptive immune system. This kind of classification not only represents the 
sequences of hurdles a pathogen needs to overcome to establish the infection but 
also the evolutionary pathway from early immune mechanisms shared by plants 
and animals to the most advanced and complex immune system of vertebrates 
(Delves and Roitt, 2000a, 2000b; Rodríguez et al., 2012). 
The skin and mucosal surfaces represent physical barriers to infection. The 
innate immune system is comprised of a conglomeration of soluble factors and 
cells that detect and respond to infectious agents through binding to relatively 
nonspecific structures common to many pathogens - PAMPs (Pathogen-
associated molecular patterns). The adaptive immune system is comprised of T- 
and B-lymphocytes that recognize highly specific structures (antigens) on 
microorganisms via highly diverse membrane receptors that are generated 
randomly and are uniquely tailored to individual pathogens (Rodríguez et al., 
2012). 
Innate immune responses to infection are rapid (minutes) whereas 
adaptive immune responses are delayed (days). Innate immune responses are 
broadly similar between individuals within a population and are generally 
considered not to improve upon repeated exposure to infectious agents. 
Adaptive immune responses differ between individuals and improve upon a 
second or subsequent encounter with the same antigen. 
Innate and adaptive immune responses in vertebrates are highly 
interdependent and cooperate to counteract the infectious agents. 
Vinko Tosevski 
8 
 
Barriers against infection 
Microorganisms are kept out of the body by the skin, the secretion of 
mucus, ciliary action, the lavaging action of bactericidal fluids (e.g. tears), gastric 
acid and microbial antagonism. 
Immate immunity 
Immune responses are initiated through detection of PAMPs representing 
non-self or danger-associated molecular patterns (DAMPs) that represent hidden 
self. Pattern recognition receptor molecules (PRRs), which can be either soluble 
(humoral) or cell-associated, are used by the immune system to detect the 
presence of PAMPs or DAMPs. PRR engagement leads to a diversity of responses 
that are aimed at directly killing or engulfing microorganisms via phagocytosis, 
and also results in amplification of immune responses through release of a range 
of molecules such as cytokines and chemokines (Matzinger, 1994). 
The main phagocytic cells are polymorphonuclear neutrophils and 
macrophages. The phagocytic cells use their membrane-localized pattern 
recognition receptors to recognize and adhere to pathogen-associated molecular 
patterns on the microbe surface. PRRs include Toll-like, C-type lectin, NOD-like, 
RIG-like and scavenger receptors. PRR engagement leads to activation of 
phagocyte functions and to secretion of a range of cytokines and chemokines, 
many of which are expressed in an NFκB- and IRF-dependent manner. 
Organisms adhering to the phagocyte surface activate the engulfment process 
and are taken inside the cell where they fuse with cytoplasmic granules. An array 
of microbicidal mechanisms is, then, available to deactivate the endocytosed 
organism: the conversion of molecular oxygen to reactive oxygen intermediates, 
the synthesis of nitric oxide and the release of multiple oxygen-independent 
factors from the granules. Adherence to PRRs on dendritic cells initiates adaptive 
immune processes. 
The complement system, a multicomponent-triggered enzyme cascade, is 
used to attract phagocytic cells to the microbes and engulf them. Complement 
activation also leads to a formation of membrane attack complex (MAC) that 
perforates microorganisms. 
In what is known as the alternative complement pathway, the most 
abundant component, C3, is split by a convertase enzyme formed from its own 
cleavage product C3b and factor B and stabilized against breakdown caused by 
factors H and I, through association with the microbial surface. As it is formed, 
C3b becomes linked covalently to the microorganism and acts as an opsonin. The 
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next component, C5, is activated yielding a small peptide, C5a; the residual C5b 
binds to the surface and assembles the terminal components C6–9 into a 
membrane attack complex which is freely permeable to solutes and can lead to 
osmotic lysis. C5a is a potent chemotactic agent for neutrophils and greatly 
increases capillary permeability. C3a and C5a act on mast cells causing the 
release of further mediators, such as histamine, leukotriene B4 and tumor necrosis 
factor (TNF), with effects on capillary permeability and adhesiveness, and 
neutrophil chemotaxis. This series of events leads to inflammation. 
Inflammation is the term used to describe the events that surround an 
immune response and includes local swelling (due to recruitment of phagocytes 
and plasma proteins from blood), redness, pain and temperature elevation. 
Following the activation of complement with the ensuing attraction and 
stimulation of neutrophils, the activated phagocytes bind to the C3b-coated 
microbes by their surface C3b receptors and may then ingest them. The influx of 
polymorphonuclear cells and the increase in vascular permeability constitute the 
potent antimicrobial acute inflammatory response. Inflammation can also be 
initiated by tissue macrophages when signaling by bacterial toxins, C5a- or iC3b- 
coated bacteria adhering to surface complement receptors causes release of 
neutrophil chemotactic and activating factors. 
In additiona to a plethora of membrane-bound PRRs, there exists also a 
multitude of soluble pattern recognition molecules belonging to several protein 
families (e.g. pentraxins, collectins, ficolins). Mechanisms of action common to 
these soluble PRRs upon binding their targets include: opsonization, complement 
activation, enhanced phagocytic uptake and agglutination (Bottazzi et al., 2010). 
For instance, the synthesis of acute phase proteins, such as C-reactive and 
mannose-binding proteins, is greatly augmented by infection. Mannose-binding 
lectin generates a complement pathway that is distinct from the alternative 
pathway in its early reactions. It is a member of the collectin family that includes 
conglutinin and surfactants SP-A and SP-D, notable for their ability to distinguish 
microbial from “self” surface carbohydrate groups by their pattern recognition 
molecules. 
Natural killer (NK) cells are innate effector lymphocytes necessary for 
defence against stressed, microbe-infected, or malignant cells. NK cells kill target 
cells by either of two major mechanisms that require direct contact between NK 
cells and target cells. In the first pathway, cytoplasmic granule toxins, 
predominantly a membrane-disrupting protein perforin and a family of 
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structurally related serine proteases (granzymes) with various substrate 
specificities, are secreted by exocytosis and together induce apoptosis of the 
target cell. The granule-exocytosis pathway potently activates cell-death 
mechanisms that operate through the activation of apoptotic cysteine proteases 
(caspases), but can also cause cell death in the absence of activated caspases. The 
second pathway involves the engagement of death receptors (e.g. Fas/CD95) on 
target cells by their cognate ligands (e.g. FasL) on NK cells, resulting in classical 
caspase-dependent apoptosis - a coordinated internal dismantling of critical 
cellular structures, resulting in a cell death (Smyth et al., 2005). 
Large infectious agents that are physically too big to be readily 
phagocytosed by macrophages and neutrophils are "handled" by eosinophils or 
basophils. They harbor specific cytoplasmic granules that contain a series of 
cationic toxins able to kill many targets, including helminths, protozoa, bacteria, 
and other cells. In bronchial asthma, considerable evidence exists that the 
eosinophil releases granule proteins, especially the major basic protein (MBP), 
which in turn mediate tissue abnormalities (Gleich et al., 1993). 
Dendritic cells (DCs) provide a conduit between the innate and adaptive 
immune system by presenting antigen to T-lymphocytes within secondary 
lymphoid tissues and peripheral tissues. Like macrophages and neutrophils, DCs 
are considered professional phagocytes. Even if the three cell types phagocytose 
parasites, bacteria, cell debris, or even intact cells very efficiently, the functional 
outcomes of the phagocytic event are quite different. Macrophages and 
neutrophils scavenge and destroy phagocytosed particles, a critical step in innate 
immunity. DCs, in contrast, have developed means to 'preserve' useful 
information from the ingested particles that serve to initiate adaptive immune 
responses. Thus, both phagosomal degradation and acidification are much lower 
in DCs than in macrophages or neutrophils. Reduced degradation results in the 
conservation of antigenic peptides and in their increased presentation on major 
histocompatibility complex class I and II molecules (Signal 1). At the same time 
they also provide co-stimulatory signals via B7 family ligands (signal 2). Both 
signals are required for efficient T-cell activation. PAMP-mediated stimulation of 
DCs triggers their maturation (i.e. the ability to efficiently present antigen and 
provide co-stimulation) and promotes their migration to lymph nodes (Savina 
and Amigorena, 2007). 
Other cell types of the innate immune system sharing features with T cells 
are the NKT and γδT cells. NKT cells develop in the thymus, but their T cell 
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receptor (TCR) is invariant and recognizes glycolipids presented by non-variant  
CD1d molecule. Due to the rearranging of their TCR genes and the potential to 
develop a memory phenotype, γδT cells more closely resemble the cells of the 
adaptive immune system and provide an additional "brifge" between the two 
(Born et al., 2006). 
Monocytes stem from haematopoietic stem cell precursors in the bone 
marrow and, once released into the blood stream, migrate rapidly to sites of 
infection and differentiate into macrophages and DC. 
Adaptive immunity 
The adaptive arm of the immune system implements the power of random 
somatic rearrangement and somatic hypermutation to generate almost unlimited 
antigen recognition potential through a cellular system that grants the organism 
long lasting protection (immunological memory). Lymphocytes, which are 
divided into B and T cells, are its cellular constituents. B cells are of 
hematopoietic origin and are generated in the bone marrow where they 
differentiate into mature resting B cells. T cell precursors also originate in the 
bone marrow but migrate into the thymus to differentiate into T cells under the 
guidance of the local stroma. Each clone of B and T cells carries a unique receptor 
which enables it to detect foreign antigen. B cells and T cells were discovered 
around the same time following a hypothesized cellular division of those that 
produce antibodies and originate from the bursa fabricii in birds (place of B cell 
haematopoiesis in birds; origin of the term B cell) and those responsible for a 
delayed hypersensitivity (DTH) response and are thymus derived (COOPER et 
al., 1965). 
B cells provide the body’s humoral immunity through the production of 
antigen specific antibodies. Antibodies are soluble B cell receptors (BCRs) that B 
cells secrete in response to immunogenic stimulation. Antibodies/BCRs consist of 
a highly diverse part which is randomly assembled by an error-prone genetic 
rearrangement of the V(D)J loci and a constant region (Fc) which defines the 
isotype of the antibody. In mice and humans five classes of antibodies exist: IgM, 
IgD, IgG, IgA and IgE. The isotype defines the function and localisation of the 
antibody. The induction of a B cell response culminates in a germinal centre 
reaction in secondary lymphoid organs leading to the immediate generation of 
antibody producing short lived plasma blasts and affinity matured (product of 
somatic hypermutation), class switched, long-lived plasma cells (memory B cells) 
(LeBien and Tedder, 2008). Secreted antibodies have several roles in immunity: 
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(a) Neutralisation of antigen structures on the surface of pathogens. (b) 
Opsonisation of pathogens, which directs killing of the pathogen via 
phagocytosis or the complement system. (c) Marking pathogens for subsequent 
Fc-receptor mediated effector functions of other leukocytes. 
T cell constitute a cellular "branch" of adaptive immunity. Unlike B cells, T 
cells do not recognize native structures but only peptide antigens presented in 
the context of MHC molecules by APCs. Their development occurs in the thymus 
from undifferentiated T cell precursors, thymocytes. Generation of the TCR 
subunits also involves genomic rearrangement of V(D)J elements and the 
variability is further increased by a random insertion of nucleotides at most 
joining sites (N-regions). The TCR is a heterodimer consisting of two 
transmembrane proteins, either an alpha and beta- or a gamma and delta chain. 
Either expression determines the lineage fate (von Boehmer and Waldmann, 
2010). 
The TCR specificity is unpredictable and has potential binding capabilities 
towards any possible antigen, including self antigens. The thymic positive and 
negative selection processes eliminate those T cell clones from the T cell 
repertoire that do not bind (MHC restriction) or bind strongly to self-
peptide:MHC complex (spMHC) (recessive/central tolerance). Most of the 
selection takes place in the medullary region of the thymus where peripheral self-
antigens are presented on MHC by immigrating DCs (Bonasio and von Andrian, 
2006) and/or medullary epithelial cells by AIRE-dependent ectopic gene 
expression (Anderson, 2002). The weak interaction between the TCR and spMHC 
that is necessary to pass positive selection is usually not sufficient to elicit an 
autoimmune response but acts as a survival signal that is crucial in T cell 
homeostasis. Besides the weak TCR signalling common γ chain (γc) cytokines 
(IL-2, IL-7 and IL-15) and their receptors on the T cells regulate T cell survival 
and expansion (Surh and Sprent, 2008). 
Two major subtypes of T cells can be distinguished based on their MHC 
restriction. CD4+ T cells are MHC class II restricted and recognize antigens 
presented in the context of MHC class II molecule. CD8+ T cells, also known as 
cytotoxic lymphocytes (CTL), are MHC I restricted and recognize antigens 
presented in the context of the ubiquitously expressed MHC class I molecule. 
CD4+ T cells that leave the thymus can be divided into 3 distinct lineages: 
T helper cells (Th cells), natural regulatory cells and natural killer T cells (NKT 
cells). T helper cells are the central cell type in adaptive immunity. They are 
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behooved to (a) help B cells produce antibodies, (b) regulate CTL activation, (c) 
recruit granulocytes to the site of inflammation, (d) stimulate anti-microbial 
activity by macrophages and (e) orchestrate the overall cellular immune response 
by the secretion of various cytokines. Loss, misguidance or uncontrolled 
autoreactivity of Th cells can have a detrimental effect on the organism leading to 
immunodeficiency, allergy or autoimmunity respectively. 
Cytotoxic T cells, if properly primed, home into peripheral tissue and are 
activated by the foreign peptide:MHC complex on the surface of a cell and in 
turn start their cytotoxic response which destroys the target cell and contributes 
to shaping the cytokine milieu at the site of infection. Due to their destructive 
capacity their priming has to be tightly controlled. A CTL can only become active 
when a CD4+ T cell counterpart of the CTL is activated and subsequently licenses 
a DC that cross-presents their cognate antigen on MHC I. Only then the DC can 
give sufficient costimulatory signal to prime the CTL. 
Nervous system 
The nervous system is possibly the most complex body system of all, 
whose purpose is to transmit signals between different parts of the body, 
coordinate voluntary and involuntary actions of the organism, bridge the sensory 
structures and other organic systems that respond to them and store memories 
and similar-level information being generated in the organism’s interaction with 
the environment. The nervous system receives each minute literally millions of 
bits of information from the different sensory nerves and sensory organs and 
then integrates all these to determine responses to be made by the body. In many 
types of organisms, the nervous system consists of two main parts – central 
nervous system (brain and spinal cord) and peripheral nervous system (nerve 
fibers). In terms of composition, the nervous system consists of neurons and glial 
cells. 
The basic structure of neurons resembles that of other cells. Thus, each 
nerve cell has a cell body containing a nucleus, endoplasmic reticulum, 
ribosomes, Golgi apparatus, mitochondria, and other organelles that are essential 
to the function of all cells. A particularly noteworthy morphological feature of 
most nerve cells is the elaborate branching of the dendrites (also called dendritic 
branches or dendritic processes) that arise from the neuronal cell body. The 
spectrum of neuronal geometries ranges from a small minority of cells that lack 
dendrites altogether to neurons with dendritic branches that rival the complexity 
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of a mature tree. The number of inputs that a particular neuron receives depends 
on the complexity of its dendritic tree. Nerve cells that lack dendrites are 
innervated by just one or a few other nerve cells, whereas those with increasingly 
elaborate dendrites are innervated by a commensurately larger number of other 
neurons (Purves et al., 2001a). The human central nervous system contains more 
than 100 billion neurons. Incoming signals enter the neuron through synapses 
located mostly on the neuronal dendrites, but also on the cell body. For different 
types of neurons, there may be only a few hundred or as many as 200,000 such 
synaptic connections from input fibers. Conversely, the output signal travels by 
way of a single axon leaving the neuron. Then, this axon has many separate 
branches to other parts of the nervous system or peripheral body. A special 
feature of most synapses is that the signal normally passes only in the forward 
direction (from the axon of a preceding neuron to dendrites on cell membranes of 
subsequent neurons). This forces the signal to travel in required directions for 
performing specific nervous functions (Guyton, 2006). 
Neuroglial cells—usually referred to simply as glial cells or glia—are quite 
different from nerve cells. The major distinction is that glia do not participate 
directly in synaptic interactions and electrical signaling, although their 
supportive functions help define synaptic contacts and maintain the signaling 
abilities of neurons. Glia are more numerous than nerve cells in the brain, 
outnumbering them by a ratio of perhaps 3 to 1. Although glial cells also have 
complex processes extending from their cell bodies, they are generally smaller 
than neurons, and they lack axons and dendrites. The term glia (from the Greek 
word meaning “glue”) reflects the nineteenth-century presumption that these 
cells held the nervous system together in some way. The word has survived, 
despite the lack of any evidence that binding nerve cells together is among the 
many functions of glial cells. Glial roles that are well-established include 
maintaining the ionic milieu of nerve cells, modulating the rate of nerve signal 
propagation, modulating synaptic action by controlling the uptake of 
neurotransmitters, providing a scaffold for some aspects of neural development, 
and aiding in (or preventing, in some instances) recovery from neural injury. 
There are three types of glial cells in the mature central nervous 
system: astrocytes, oligodendrocytes, and microglial cells. 
Astrocytes, which are restricted to the brain and spinal cord, have 
elaborate local processes that give these cells a star-like appearance (hence the 
THE EFFECTS OF INTERFERON GAMMA DEFICIENCY ON THE AUTOIMMUNE INFLAMMATION OF THE CENTRAL NERVOUS SYSTEM 
15 
 
prefix “astro”). The major function of astrocytes is to maintain, in a variety of 
ways, an appropriate chemical environment for neuronal signaling. 
Oligodendrocytes, which are also restricted to the central nervous system, 
lay down a laminated, lipid-rich wrapping called myelin around some, but not 
all, axons. Myelin has important effects on the speed of action 
potential conduction. In the peripheral nervous system, the cells that elaborate 
myelin are called Schwann cells. 
Microglial cells are smaller cells derived from hematopoietic stem cells. 
They share many properties with tissue macrophages, and are primarily 
scavenger cells that remove cellular debris from sites of injury or normal cell 
turnover. Indeed, some neurobiologists prefer to categorize microglia as a type of 
macrophage. Following brain damage, the number of microglia at the site of 
injury increases dramatically. Some of these cells proliferate from microglia 
resident in the brain, while others come from macrophages that migrate to the 
injured area from the circulation (Purves et al., 2001b). 
Three major levels of the central nervous system have specific functional 
characteristics: (a) the spinal cord level, (b) the lower brain or subcortical level, 
and the (c) higher brain or cortical level. 
We often think of the spinal cord as being only a conduit for signals from 
the periphery of the body to the brain, or in the opposite direction from the brain 
back to the body. This is far from the truth. Even after the spinal cord has been 
cut in the high neck region, many highly organized spinal cord functions still 
occur. For instance, neuronal circuits in the cord can cause (a) walking 
movements, (b) reflexes that withdraw portions of the body from painful objects, 
(c) reflexes that stiffen the legs to support the body against gravity, and (d) 
reflexes that control local blood vessels, gastrointestinal movements, or urinary 
excretion. In fact, the upper levels of the nervous system often operate not by 
sending signals directly to the periphery of the body but by sending signals to the 
control centers of the cord, simply “commanding” the cord centers to perform 
their functions. 
Many, if not most, of what we call subconscious activities of the body are 
controlled in the lower areas of the brain—in the medulla, pons, mesencephalon, 
hypothalamus, thalamus, cerebellum, and basal ganglia. For instance, 
subconscious control of arterial pressure and respiration is achieved mainly in 
the medulla and pons. Control of equilibrium is a combined function of the older 
portions of the cerebellum and the reticular substance of the medulla, pons, and 
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mesencephalon. Feeding reflexes, such as salivation and licking of the lips in 
response to the taste of food, are controlled by areas in the medulla, pons, 
mesencephalon, amygdala, and hypothalamus. And many emotional patterns, 
such as anger, excitement, sexual response, reaction to pain, and reaction to 
pleasure, can still occur after destruction of much of the cerebral cortex. 
After the preceding account of the many nervous system functions that 
occur at the cord and lower brain levels, one may ask, what is left for the cerebral 
cortex to do? The answer to this is complex, but it begins with the fact that the 
cerebral cortex is an extremely large memory storehouse. The cortex never 
functions alone but always in association with lower centers of the nervous 
system. Without the cerebral cortex, the functions of the lower brain centers are 
often imprecise. The vast storehouse of cortical information usually converts 
these functions to determinative and precise operations. Finally, the cerebral 
cortex is essential for most of our thought processes, but it cannot function by 
itself. In fact, it is the lower brain centers, not the cortex, that initiate wakefulness 
in the cerebral cortex, thus opening its bank of memories to the thinking 
machinery of the brain. Thus, each portion of the nervous system performs 
specific functions. But it is the cortex that opens a world of stored information for 
use by the mind (Guyton, 2006). 
Immunity and the central nervous system 
In terms of its immunological status, central nervous system has 
historically been seen as immunologically privileged site - it was believed that 
brain does not reject foreign tissue grafts, is devoid of classical APCs, lacks 
constitutive MHC I and II expression on parenchymal cells and has no lymphatic 
vessels. However, according to the modern understanding of the immunity of the 
CNS, this "immune privilege" is seen more as an "immune specialization", since 
common hallmarks of tissue inflammatory response, like edema, would be 
detrimental for the delicate network of cells that make the CNS (Engelhardt and 
Ransohoff, 2005). 
Generally, rather strong blood-tissue barriers, low permeability to 
hydrophilic compounds and carrier-mediated transport systems act as a 
protection of "privileged" site. Functionally insignificant levels of complement 
reduce the threat of acute inflammatory reactions and unusually high 
concentrations of immunosuppressive cytokines, such as IL-10 and TGFβ act as a 
safeguard against potential uncontrolled immune cell activity. Immune privilege 
can also be maintained by Fas (CD95)-induced apoptosis of autoaggressive cells.  
THE EFFECTS OF INTERFERON GAMMA DEFICIENCY ON THE AUTOIMMUNE INFLAMMATION OF THE CENTRAL NERVOUS SYSTEM 
17 
 
Tolerance and autoimmunity 
An autoimmune disease is a medical condition that occurs when the 
immune system inflicts damage to the organism's own tissues or cells. The 
potential for developing autoimmunity is inherent in a way adaptive immunity 
develops - the randomness of the process can also produce BCRs/TCRs specific 
for self-antigens. However, this doesn't happen most of the time and the concept 
is called tolerance towards self and functions on two levels: (a) central and (b) 
peripheral tolerance. Central tolerance works by eliminating self-reactive T cells 
that emerge during the thymic development. The importance of central tolerance 
is shown by deficiency of the autoimmune regulator Aire in humans and mice, 
which leads to a multiorgan autoimmune disease called the Autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) (Cetani et al., 
2001). Peripheral tolerance is the mechanism by which mature T cells that 
recognize self antigen in the periphery (e.g. because they escaped negative 
selection or their antigen was not presented in the thymus) are rendered 
innocuous. This is achieved by anergy, suppression through Tregs or deletion. 
There are around 80 different autoimmune diseases recognized so far and 
they affect approximately 5% of the population in Western countries, with a 
higher prevalence in females. Based on their restriction, they can be categorized 
into systemic (e.g. systemic lupus erythematosus, rheumatoid arthritis) and 
organ-specific autoimmune diseases (e.g., multiple sclerosis, autoimmune 
thyroiditis). All of them tend to have both genetic and environmental 
background. For example, as mentioned, mutations in the Aire gene lead do 
autoimmunity and many other genes have been strongly correlated with certain 
diseases, so-called risk alleles (DRB1*1501 in MS, for instance) (International 
Multiple Sclerosis Genetics Consortium et al., 2007). But the fact that healthy 
people can carry those same alleles suggests that there is also an environmental 
factors that likely play a role. Viral and bacterial infections can contribute in two 
different ways: A local immune response can be mediated by activation of 
costimulatory molecules and cytokine production which in turn can break 
tolerance and result in a bystander activation unspecific for the pathogen but 
directed against a self antigen. The second possibility is molecular mimicry: a 
pathogen might contain an antigen structurally similar to a self antigen 
(mimicking the self antigen) and therefore elicit an immune response against self. 
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MS 
Multiple sclerosis (MS) is the most common neurological disorder in 
young adults in the developed world. It is a complex disease with heterogeneous 
clinical, pathological and immunological phenotype that might better be 
described as a syndrome rather than a single disease entity—a concept that has 
important implications with respect to the development of effective therapeutic 
strategies. The clinical heterogeneity of multiple sclerosis has been recognized for 
many years, but it is now apparent that this heterogeneity extends to both the 
genetics of the disease and the pathological mechanisms involved in lesion 
formation. Clinically the illness may present itself as a relapsing–remitting 
disease, or with steady progression of neurological disability. The subsequent 
course of disease is unpredictable, although most patients with a relapsing– 
remitting disease will eventually develop secondary progressive disease. 
Advances in molecular medicine have clearly demonstrated the heterogeneity of 
multiple sclerosis (Gold et al., 2006; Lassmann et al., 2001). 
EAE 
Experimental autoimmune encephalomyelitis (also historically referred to 
as autoimmune allergic encephalitis or encephalomyelitis – EAE) is currently the 
best characterized animal model of human autoimmune disease. It's origins date 
back to the 1920s, when Koritschoner and Schweinburg induced spinal cord 
inflammation in rabbits by inoculation with human spinal cord (Koritschoner 
and Schweinburg, 1925). In the 1930s, researchers attempted to reproduce the 
encephalitic complications associated with rabies vaccination by repetitive 
immunization of rhesus monkeys with CNS tissue (Rivers and Schwentker, 1935; 
Rivers et al., 1933). In years to come it became clear that EAE can reproduce 
many of the clinical, neuropathological and immunological aspects of multiple 
sclerosis (WOLF et al., 1947). However, EAE did not make it into the mainstream 
research at the beginning since the process of disease induction in laboratory 
animals was laborious and lengthy (repeated injections over a period of a year). It 
took almost two decades before the procedure was facilitated through use of 
newly developed oil-based adjuvants and addition of heat-inactivated 
mycobacteria tuberculosis to it (Kabat et al., 1951). 
Although sometimes criticized for its inadequacy as a model of multiple 
sclerosis (Sriram and Steiner, 2005) it is a valuable tool for studying basic 
principles of autoimmune inflammatory processes in the CNS. In most rodents, 
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EAE manifests itself as an ascending flaccid paralysis in rostro-caudal direction, 
reflecting the preferential localization of inflammatory foci in the spinal cord. 
This pattern of clinical features is described as classical EAE. However, in certain 
combinations of animal strain and immunizing agent, a different set of clinical 
features was described, thus dubbed atypical EAE (Greer et al., 1996; Muller et 
al., 2000). In addition, interferon gamma (IFN-γ) deficiency was also found to 
result in atypical EAE (Wensky et al., 2005; Abromson-Leeman et al., 2004). In 
atypical EAE the clinical picture is dominated by apparent defects in balance and 
proprioception. Pathohistological analysis of the CNS in these animals reveals 
increased inflammation of the brain stem and cerebellum compared to the spinal 
cord (Muller et al., 2000). 
The interferon system 
The interferons (IFNs) were originally discovered as agents that interfere 
with viral replication (Isaacs and Lindenmann, 1957). Initially, they were 
classified by the secreting cell type but are now classified into type I and type II 
according to receptor specificity and sequence homology. The type I IFNs are 
comprised of multiple IFNα subtypes, IFNβ, IFNω and IFNτ, all of which are 
structurally related and bind to a common heterodimeric receptor (IFNAR, 
comprised of IFNAR1 and IFNAR2 chains). IFNγ is the sole type II interferon. It 
is structurally unrelated to type I IFNs, binds to a different receptor, and is 
encoded by a separate chromosomal locus. The main producers of IFNγ are T 
cells and NK cells, although some other cell types have also been implicated as 
potential cellular source (Young, 1996). IFNγ production is controlled by 
cytokines secreted by APCs, most notably interleukin 12 and IL-18. These 
cytokines serve as a bridge to link infection with IFNγ production in the innate 
immune response (Otani et al., 1999). Negative regulators of IFNγ production 
include IL-4, IL- 10, TGFβ and glucocorticoids. Given the complexity of IFN-γ 
regulation, it is not surprising that inbred mouse strains vary in their ability to 
secrete this cytokine; for example, T lymphocytes of C57BL/6 and C3H mice 
secrete significantly higher amounts of IFNγ compared with the T lymphocytes 
of BALB/c and B10.D2 mice. IFNγ coordinates a diverse array of cellular 
programs through transcriptional regulation of immunologically relevant genes 
(Schroder et al., 2004).  
Functional IFNγ receptor (IFNGR) is comprised of two ligand-binding 
IFNGR1 chains associated with two signal-transducing IFNGR2 chains and 
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associated signaling machinery. IFNGR1 and IFNGR2 chains belong to the class 
II cytokine receptor family, a class of receptors that bind ligand in the small angle 
of a V formed by the two Ig-like folds that constitute the extracellular domain 
(Thoreau et al., 1991). The IFNGR2 chain is generally the limiting factor in IFNγ 
responsiveness, as the IFNGR1 chain is usually in surplus (Bernabei et al., 2001). 
The IFNGR2 chain is constitutively expressed, but its expression level may be 
tightly regulated according to the state of cellular differentiation or activation 
(Bach et al., 1997). Both IFNGR chains lack intrinsic kinase/phosphatase activity 
and so must associate with signaling machinery for signal transduction. The 
IFNGR1 intracellular domain contains binding motifs for the Janus tyrosine 
kinase (Jak)1 and the latent cytosolic factor, signal transducer and activator of 
transcription (Stat)1. The intracellular region of IFNGR2 contains a 
noncontiguous binding motif for recruitment of Jak2 kinase for participation in 
signal transduction. 
Mice without the IFNγ receptor had no overt anomalies, and their 
immune system appeared to develop normally. However, mutant mice had a 
defective natural resistance, they had increased susceptibility to infection by 
Listeria monocytogenes and vaccinia virus despite normal cytotoxic and T helper 
cell responses (Huang et al., 1993). 
In addition to recurrent infection, infants with deficient production of 
IFNγ exhibited decreased neutrophil mobility and NK cell activity, highlighting 
the importance of IFN-γ in the inflammatory response and immunoregulation 
(Davies et al., 1982). 
Cre-LoxP system 
The Cre/loxP recombination system is the most widely used system for 
cell-type-specific gene inactivation. The core of this system is the Cre 
recombinase, a protein from bacteriophage P1, which mediates recombination of 
specific sequences called loxP sites. When two loxP sites are introduced into the 
genome in the same orientation and the Cre recombinase is expressed, the Cre 
will recombine the loxP sites and delete the sequence between the sites. In this 
way the Cre/loxP system can be used to delete genes or critical parts of genes. 
The system is also widely used for conditional gene activation. In this setting a 
cassette that is blocking transcription, a so-called ‘‘stop-cassette’’ that is flanked 
by loxP sites, is introduced between a promoter and the translational start site of 
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a gene. Thus, the gene is silent under basal conditions but activated upon Cre-
mediated removal of the stop-cassette (Sauer, 1993). 
Cre fusion proteins have been developed which are inactive in the basal 
state since they are fused to a modified ligand-binding domain of the estrogen 
receptor and thus kept in the cytoplasm. Upon binding of tamoxifen, a synthetic 
steroid, the fusion protein is translocated to the nucleus and the Cre is able to 
perform the recombination of the loxP sites. Furthermore, in order to restrict gene 
inactivation in a certain cell-type or tissue, the Cre fusion protein can be 
expressed under a tissue-type-specific gene promoter (Feil et al., 2009). 
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Matherials and Methods 
Mice and animal experiments 
All mice were kept in-house in individually ventilated cages under 
specific pathogen-free (SPF) conditions. C57BL/6 (wild-type) mice were 
purchased from Janvier. 
IFNγ-KO mice (GKO) were obtained from Jackson Laboratories. 
IFNGR1-KO mice were obtained from Jackson Laboratories. 
Ifngr2tm1Hzi mice were obtained from Prof. Werner Muller, University of 
Manchester. 
Nestin-Cre mice were obtained from Prof. Max Gassmann, University of 
Zurich. 
VE-Cadherin-Cre mice were obtained from Prof. Cornelia Halin Winter, 
ETH Zurich. 
CX3CR1-CreERt2 mice were obtained from Prof. Steffen Jung, Weizmann 
Institute of Science. 
CD4-Cre mice were obtained from Jackson Laboratories. 
LysM-Cre mice were obtained from Jackson Laboratories. 
All animal experiments were approved by Swiss Veterinary Office and 
performed sccording to the appropriate experimental license (55-2009 and 86-
2012). 
DNA isolation and genotyping 
Biopsies were obtained either by ear-punching adult mice, or by toetip-
clipping pups before reaching the age of 12 days. Biopsies were incubated in 500 
µl tail lysis buffer containing 10 µl Proteinase K for 1-3 hours at 55°C, followed 
by centrifugation for 5 minutes at 14.000g to pellet undigested tissue. The 
supernatant was transferred to a fresh tube and 500 µl of isopropanol was added 
to precipitate the DNA, followed by centrifugation for 10 minutes at 14.000g / 
4°C. The supernatant was discarded and the DNA pellets were air-dried for 10-15 
minutes and then resuspended in 50-100 µl of TE buffer. 
For genotyping, 1 µl of the purified DNA was used as template, together 
with the appropriate primers and PCR protocols. PCR products were analyzed 
by running a standard 1-2% agarose Gel in TAE buffer. 
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Bone marrow chimeric mice. 
Bone marrow (BM) donor mice were euthanized using CO2 and BM cells 
were isolated by flushing femur, tibia, humerus and hip bones with phosphate-
buffered saline (PBS). BM cells were filtered through a 70-μm cell strainer (BD) 
and cells were washed with PBS. Recipient mice were lethally irradiated with 
1100 rads (split dose) and intravenously injected with 10 × 106 BM cells. 
Engraftment took place over the following 6 weeks of recovery. Mice were 
examined prior to EAE induction to assess the extent of engraftment of donor-
derived leukocytes. 
Induction and scoring of EAE. 
Experimental autoimmune encephalomyelitis (EAE) was induced as 
described previously (Gyülvészi et al., 2009). Briefly, mice were immunized 
subcutaneously in the flanks with a total amount of 200 µg of MOG35-55 peptide 
(MEVGWYRSPFSRVVHLYRNGK; GenScript) emulsified in CFA (Difco) in a 
total volume of 200 µl and two intraperitoneal injections of 200 ng Pertussis toxin 
(Sigma) on day 0 and 2. For immunization of bone marrow chimeric mice same 
procedure was followed but the usage of pertussis toxin was omitted. 
For passive EAE induction, spleen and lymph node cells were harvested 
from donor mice of the indicated genotype on day 7 post immunization, re-
stimulated in vitro for two days with 20 µg/ml MOG and 20 ng/ml IL-23 and then 
i.v. transferred to recipients who were sub-lethally irradiated (550 Rad) one day 
before the transfer. 
Mice were assessed clinically by daily weighing and observation. Classical 
EAE signs were assessed according to the following criteria: 0, no disease; 1, 
decreased tail tone or slightly clumsy gait; 2, tail atony and/or moderately clumsy 
gait and/or poor righting ability; 3, limb weakness; 4, limb paralysis; 5, moribund 
state. 
The severity of atypical EAE was assessed according to the criteria 
adapted from previous publications (Greer et al., 1996): 0, No detectable signs; 1, 
Head turning; 2, Pronounced head turning and body leaning to the side; 3, 
Inability to walk straight; 4, Inability maintain upright posture without support; 
5, rolling and spinning in axial direction. 
Since different grading scales are used to asses disease progression of 
classic and atypical EAE, the results are never depicted on the same graph. 
Sometimes the individual mouse will display combination of atypical and classic 
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symptoms (limp distal tail and tilted body posture, for instance) which 
complicates the assignment of the unique score and further supports the 
approach of depicting disease progression curves as two independent graphs. It 
sometimes occurs (most often at the disease onset) that an animal displays classic 
or atypical disease symptom, only to switch to a different group of symptoms the 
next day. To accommodate these occurrences, the criteria for declaring a strain as 
displaying atypical disease were defined as minimum of two consecutive days of 
showing unambiguous atypical symptoms. In our hands, unlike reported 
elsewhere (Stromnes and Goverman, 2006), the symptoms of atypical EAE in 
mouse strains with a specific genetic makeup tend to appear in chronological 
order and are backed up with the progressive weight loss. Sporadic, non-
enduring occurrences of atypical EAE symptoms do not show this regular 
increasing pattern. 
Tamoxifen treatment 
Mice (starting from 4 weeks of age) were fed with Tamoxifen food pellets 
(Harlan Teklad CRD TAM400/CreER) containing 400 mg tamoxifen/kg for 3 - 4 
weeks. Mice were monitored for their behavior and health status. 
Mice were injected i.p. with 2.5µg of tamoxifen (Sigma, T56481G) 
dissolved in 50µL of corn oil (Sigma, C8267) every second day, total of 4 times. 
Leukocyte isolation from the tissues 
CNS 
Mice are euthanized with CO2 followed by the transcardial perfusion with 
PBS through the left ventricle. The animal is decapitated at the level of the 
shoulders and spinal cord is removed by flushing the spinal column with sterile 
PBS through the incision at the base of the column. The brain is dissected by 
opening the top of the scull and removing the brain with metal spatula. Both 
tissues are homogenized and cell suspension filtered through a 100 mum nylon 
filter (Fisher). After centrifugation, the pellet is resuspended in 30% isotonic 
Percoll. The sample is centrifuged at 10000 g for 25 min at 4 °C, without brakes. 
The myelin fraction forms a thick layer on the surface and is sucked away. The 
remaining, leukocyte-containing fraction is collected in a new tube, omitting the 
fraction at the bottom that contains erythrocytes. Collected leukocytes are 
additionally washed and prepared for staining. 
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Lung 
For lymphocyte isolation from the lung, lungs were cut into small pieces 
using scissors and incubated in 1 mg/ml collagenase D (Roche) and 0.1 mg/ml 
DNase (Sigma) in RPMI for approximately 60 minutes at 37°C. Remaining pieces 
of tissue were homogenized using syringes and 20 gauge needles. The cell 
suspension was filtered via 70 μm cell strainers and washed with PBS. RBC lysis 
was performed using 1 ml of RBC lysis buffer and 8 minutes of incubation on ice, 
followed by a washing step with PBS. The obtained cells were used for further 
procedures. 
Histological analysis  
Samples of CNS tissues were perfused with PBS and fixed by immersion 
in formalin. To visualize the infiltrating immune cells at the site of inflammation, 
tissue sections were stained with hematoxylin and eosin (H&E). The extent of 
demylination was assessed based on Luxol fast blue/Periodic acid Schiff 
(LFB/PAS) staining. 
Formalin-fixed samples were embedded in paraffine and co-stained with 
primary antibody rabbit anti–phospho-STAT1 (detecting only phosphorylated 
STAT1 at position Tyrosine 701; Cell Signaling Technology) together with either 
mouse anti-neuronal nuclei NeuN (Neurons, EMD Millipore) or mouse anti-glial 
fibrillary acidic protein (astrocytes; Dako) or mouse anti-NogoA 
(oligodendrocytes, mAb11c7 (Oertle et al., 2003)) or rat anti-mouse Mac3 
(microglia/macrophages; BD Pharmingen) antibody. Bound primary antibodies 
were visualized using the appropriate species-specific Cy2- or Cy3-conjugated 
secondary antibodies (all from Jackson ImmunoResearch Laboratories, Inc.) with 
DAPI (Sigma-Aldrich) nuclei for fluorescence microscopy. Stained slides were 
subsequently scanned using the 3D Histech 250 Flash slide scanner at 200-fold 
magnification to evaluate cellular colocalization of nuclear P-STAT1 signal with 
aforementioned cell specific marker. 
Flow Cytometry 
For flow cytometric analysis, the following Abs were used: 
 
Clone Target Manufacturer 
GK1.5 CD4 BioLegend / BD 
M1/70 CD11b BioLegend 
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N418 CD11c BioLegend 
30F11 CD45 BioLegend / BD 
MEL-14 CD62L BD 
M5/114.15.2 I-A/I-E BioLegend 
Al-21 or HK1.4 Ly6C BD / eBioscience 
1A8 Ly6G BD 
XMG1.2 IFN- BioLegend / BD 
TC11-18H10 or 17B7 IL-17 BioLegend / BD 
MP1-22E9 GM-CSF BD 
4a pSTAT1 BD 
 
The cells were acquired and analyzed using the FACSCanto II and 
LSRFortessa (BD) with FACSDiva software. Cell sorting was carried out using a 
FACSAria III (BD). Postacquisition analysis was performed using FlowJo 
software. For all experiments, dead cells were excluded from the analysis using 
an Aqua Live/Dead fixable staining reagent (Invitrogen) (Perfetto et al., 2010), 
and doublets were excluded by FSC-Area vs FSC-Height gating.  
For intracellular cytokine staining, cells were incubated 3-5 hours in RPMI-
1640 containing 10% FCS with PMA (50ng/ml), Ionomycin (500ng/ml) and 
GolgiPlug (containing Brefeldin A, BD, 1:1000 dilution). Cytofix/Cytoperm (BD) 
was used according to the manufacturer's instructions, and Perm/Wash Buffer 
was either obtained from BD or prepared in-house. 
Intranuclear staining of phosphorilated STAT1 was performed according 
to the manufacturer's instructions. Surface epitopes of cells were first stained, 
followed by 30 minutes stimulation with recombinant mouse IFNγ (Peprotech) at 
a concentration of 40ng/ml. Cells were fixed with formalin and permeablized 
with methanol, followed by staining with anti-pSTAT1 mAb (BD) 
Pansorbin assay 
PANSORBIN cells (Calbiochem) were dissolved in PBS at the 
concentration of 1µg/50µL and administered intranasaly to anesthetized mice. 
Animals were euthanized 6h later and lungs were transcardially perfused and 
harvested for leukocyte isolation.  
THE EFFECTS OF INTERFERON GAMMA DEFICIENCY ON THE AUTOIMMUNE INFLAMMATION OF THE CENTRAL NERVOUS SYSTEM 
27 
 
Statistical analysis 
Frequency distribution of two distinct clinical outcomes of EAE (classical 
vs. atypical) across two experimental groups (tissue-specific disruption of IFNγ 
signaling vs. intact IFNγ signaling) was tabulated in a contingency table and 
analyzed for statistical significance using the Fisher's exact test. A null-hypothesis 
(no relationship between variables) was rejected whenever a p-value was smaller 
than 0.05. 
Buffers and chemicals 
Staining buffer: 
 PBS (phosphate buffered saline, Kantonsapotheke Zurich) 
 2% FCS 
 0.005% Sodium Azide 
 
MACS buffer: 
 PBS 
 5 g of bovine serum albumin (BSA, Sigma) 
 4 ml of 0.5M EDTA 
 
Biopsy lysis buffer: 
 50 ml 1M Tris/HCl pH 7.5 
 5 ml 0.5M EDTA (AppliChem) 
 5 ml 20% SDS 
 20 ml 5M NaCl 
 ad 500ml with H2O bidest 
 
Red blood cell lysis buffer: 
 4.15 g NH4Cl 
 0.55 g KHCO3 
 0.185 g EDTA 
 ad 500 ml with H2O bidest, sterile filtration 
 
Homemade Perm/Wash Buffer: 
 PBS 
 2% BSA 
 0.5% Saponin 
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TAE buffer (50x): 
 484 g Tris base 
 14.2 ml acetic acid 
 200 ml 0.5M EDTA (pH 8.0) 
 adjust pH to 7.5 
 ad 2000 ml with H2O dest 
 
TE buffer: 
 10mM TrisCl pH 7.5 
 1mM EDTA (2 ml for 1000 ml of buffer) 
 
Digestion medium: 
 RPMI (Gibco or PAN) 
 2% FCS 
 25mM HEPES 
 
Cell culture medium for in vitro culture of lymphocytes: 
 RPMI 1640 (Gibco) 
 10% FCS 
 Penicillin/Streptamycin 
 L-Glutamin (final conc. 2mM) 
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Results 
Animals lacking IFNγ are susceptible to EAE and display atypical disease 
symptoms also in the absence of IL-17A 
It has been shown previously that neither IFNγ signaling (as in IFNγ-
deficient mice) nor IL17A/F signaling (as in IL17RA-deficient mice) are necessary 
for the development of EAE (Kroenke et al., 2010). However, the same authors 
postulated that atypical EAE seen in WT mice adoptively transferred with IFNγ-
deficient effector T cells is dependent on a functional IL17 receptor, as IL17RA-
deficient recipients revert back to the classical EAE disease course upon transfer. 
Others have suggested that atypical EAE is a feature of a disturbed Th1/Th17 
balance and occurs when the Th1/Th17 ratio is more in favor of Th17 cells 
(Stromnes et al., 2008). 
To examine how IFNγ-deficient mice respond to active EAE induction and 
investigate the role of IL17A during this process, we have generated a novel 
mouse strain that is deficient in both IFNγ and IL17A (termed DKO - Double 
KnockOut) and compared the EAE features after active induction to the ones 
seen in IFNγ- and IL17A-single-deficient mice (termed GKO and IL17A KO, 
respectively). Our results indeed support previously published reports and 
conclusions drawn from them (Lees et al., 2008; Wensky et al., 2005) and show 
that IFNγ-deficient mice predominantly succumb to the atypical form of EAE. 
However, we find IL17A to be dispensable for the occurrence of atypical EAE 
since animals deficient in both IFNγ and IL17A also display atypical disease 
symptoms (Figure 1a). To further investigate the atypical EAE course in DKO 
mice, we looked into the composition of immune cells infiltrating the CNS during 
the peak of disease. Based on previous reports, one would anticipate to find a 
large proportion of neutrophils in the CNS of mice with atypical EAE (Kroenke et 
al., 2010; Lees et al., 2008; Wensky et al., 2005). As expected, the CNS of IFNγ-
deficient mice was heavily infiltrated by neutrophils and there was no difference 
found between the brain and the spinal cord (Figure 1b and 1c). Interestingly, the 
same is true for the DKO mice. This finding rules out one of the potential 
explanations of increased neutrophil count in the inflamed brain of mice with 
atypical EAE given by Stromnes et al., suggesting that the enhanced IL17A 
activity could explain the increased recruitment of neutrophils to the site. Apart 
from neutrophilia, we found additional characteristics of immune cell 
composition that correlated with the occurrence of atypical EAE - absence of 
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monocyte-derived dendritic cells (also termed moDCs), defined according to the 
surface phenotype of CD45+ CD11b+ Ly6G- Ly6C+ MHCII+ CD11c+, and overall 
reduced proportion of infiltrating CD11b+ Ly6G- cells. 
That the neutrophils are actively recruited to the site of inflammation is 
most likely true nevertheless, since we could not observe any difference among 
the experimental groups in the amount of neutrophils circulating in the blood at 
day 7 after immunization, prior to disease onset (Figure 1d). Also, a simple assay 
of neutrophil activity and chemotactic responsiveness showed that neutrophils 
without the ability to sense IFNγ perform comparably to WT neutrophils in 
terms of responding to a potent immunogen (Figure 1e). 
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It has been suggested that atypical EAE is dependent on GM-CSF secreted 
by CD4 T cells (Kroenke et al., 2010). Furthermore, it has been shown that all 
different "lineages" of encephalitogenic effector CD4 T cells predominantly 
secrete GM-CSF in the CNS, regardless of their signature cytokine before transfer 
(Codarri et al., 2011). We observed a similar effect in our experiments, where CD4 
T cells in all 4 groups of mice predominantly secreted GM-CSF when examined at 
the peak of EAE disease (Figure 2). In fact, the only finding correlating to the 
occurrence of atypical EAE was absence of IFNγ, rather than any other change in 
the amount of cytokines commonly secreted by encephalitogenic CD4 T cells. 
We have also examined the localization of immune cells infiltrating the 
CNS and the extent of tissue damage they inflict. As expected, histopathological 
analysis of IFNγ-deficient mice showed increased infiltration of immune cells 
into the cerebellum and meninges, with many granulocytes present. Microgliosis 
and demyelination are evident and more extensive than in the spinal cord. 
Almost identical observations were made in DKO mice, suggesting that DKO and 
GKO mice indeed have many features of EAE in common (Figure 3). 
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Figure 3. Histological analysis of the brain and spinal cord of DKO, GKO, IL17A KO and WT
mice at the peak of EAE disease. Mice were sacrificed at the peak of disease and transcardially
perfused with PBS, followed by formalin. CNS was harvested, embedded in paraffine and stained
with hematoxylin and eosin, Luxol fast blue-periodic acid Schiff and Iba-1. First column 10x
magnification. Columns 2-4 60x magnification. Representative pictures of 2 independent experiments
are shown.
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Atypical EAE seen in IFNγ deficient animals is a general phenotype of the 
absence of IFNγ-signaling during autoimmune inflammation 
The finding that IL17A is dispensable for the occurrence of atypical EAE 
led us to hypothesize that the specific clinical features observed are not caused by 
the imbalanced cytokine secretion of effector CD4 T cells but rather by the 
inability of a particular cell type to sense IFNγ. To test the viability of this 
hypothesis, we have examined mice that carry no functional IFNγ receptor since 
they miss the alpha chain of the heterodimeric receptor complex (Huang et al., 
1993). Upon active immunization, these mice predominantly develop atypical 
EAE and the composition of immune cells infiltrating the CNS is dominated by 
neutrophils, phenocopying the results from IFNγ-deficient mice (figure 4a and 
4b). Taking into account also the work of Lees et al., who showed that there is no 
change in IL-17 production capacity regardless of the host's IFNγR expression 
level and clinical EAE manifestation (Lees et al., 2008), we conclude that the 
atypical EAE is a genuine phenotype of the absence of IFNγ signaling during 
autoimmune neuroinflammation and is not likely caused by the changes in 
relative amounts of cytokines normally secreted by CD4 T cells during 
neuroinflammation. 
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Phosphorylation of STAT1 can be used as a marker of IFNγ reactivity in 
vivo 
Defining cell types able to respond to the IFNγ stimulus in vivo is 
compounded by the absence of a reliable antibody to detect surface presence of 
the IFNγ receptor beta chain and by the fact that many cell types are 
unresponsive to IFNγ in a steady state but acquire responsiveness during 
particular (patho)physiological conditions (Bernabei et al., 2001). We 
hypothesized that detection of STAT1 phosphorylation, an event downstream of 
the IFNγ receptor signaling, could potentially serve as a surrogate marker of 
IFNγ responsiveness. Knowing that STAT1 is not an intermediate in the IFNγ 
signaling cascade alone, we tested the hypothesis by actively inducing EAE in 
mice sufficient (WT) or deficient in IFNγ (GKO). The extensive imaging data 
   
Figure 5. Abundance of ifngr2 mRNA in a naive mouse brain and pSTAT1 staining at the
peak of EAE.
In situ hybridization of ifngr2 mRNA in mouse brain according to Allen Mouse Brain Atlas
[Internet] ©2012 Allen Institute for Brain Science. Available from: http://mouse.brain-map.org/
(a). Immunohistochemistry of mouse brain at the peak of EAE (b) (13 mice examined).
a
GFAP Nogo AMac-3b
WT
GKO
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 available from the Allen Mouse Brain Atlas (Figure 5a) suggests that, in a resting 
mouse brain, the only cells capable of sensing IFNγ are found in the 
hippocampus and the layer of Purkinje cells in the cerebellum (Lein et al., 2007). 
However, during autoimmune inflammation of the CNS, all the cells in the brain 
(neurons, macroglia, microglia) stain positive for pSTAT1, suggesting potential 
responsiveness to IFNγ. This was confirmed in IFNγ-deficient mice, where 
pSTAT1 signal is completely absent (Figure 5b). This allows us to conclude that, 
at least during autoimmune inflammation of the CNS, no other cytokine is 
utilizing the STAT1 signaling pathway and detection of pSTAT1 could be used as 
a surrogate marker for IFNγ responsiveness in vivo. Extending our reasoning 
further, we showed that all the resident cells of the mouse brain could potentially 
be involved in driving the atypical EAE symptoms seen in IFNγ- or IFNγR-
deficient mice. 
Atypical EAE is largely mediated by a radio-resistant cell type 
 To better understand the requirements for IFNγ signaling in different 
cellular compartments, we created reciprocal bone marrow chimeras using wt 
and IFNγR1 KO mice and examined the form of EAE developed by each group. 
Lethally irradiated wild type mice were reconstituted with IFNγR1-deficient 
bone marrow and vice versa. In addition, as a control, lethally irradiated wild 
type and IFNγR1 mice were reconstituted with their respective syngeneic bone 
marrows (Figure 6). The efficiency of engraftment of donor's bone marrow was 
WT IFNγR1 -/-
Reciprocal bone marrow transplantation
WT>WT gR>WT WT>gR gR>gR
Figure 6. Schematic representation of the bone marrow chimera experiment
Recipient mice were lethally irradiated with 1100 rads (split dose) and intravenously injected with 10
 106 donor BM cells. Engraftment took place over the following 6 weeks of recovery
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found to be 94% on average as assessed by flow cytometric analysis of congeneic 
markers expressed on the surface of peripheral blood leukocytes (data not 
shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Upon active EAE induction we observed higher prevalence of atypical 
EAE in the IFNγ receptor deficient mice reconstituted with WT bone marrow 
than vice versa (Figure 7a). Comparison to the control groups led us to conclude 
that the deficiency of IFNγ signaling in the radiation-resistant cell compartment 
contributes more to the occurrence of atypical symptoms than deficiency in the 
hematopoietic compartment. 
The flow cytometric analysis revealed very high granulocyte count in the 
brains and spinal cords of the gR>gR group, with other groups showing 
moderate amounts. The moDCs were also found at lowest proportion in the brain 
and spinal cord of the gR>gR group, with other groups showing higher numbers. 
Anticipated result would have been a clear accordance of findings in 
WT>WT and gR>gR (control groups) with the ones reported previously in WT 
and GKO mice, respectively, and each experimental group fitting to one of the 
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control groups. While the composition of immune cell infiltrates in WT>WT and 
gR>gR in terms of neutrophils and moDCs indeed resembled the ones found in 
WT and GKO mice, both experimental groups resembled more the WT>WT 
control group. This was in contrast to the EAE features, where, looking at the 
prevalence of atypical EAE in the experimental groups, WT>gR resembled more 
the gR>gR and gR>WT resembled more the WT>WT group, suggesting a bigger 
role for IFNγ signaling in the radiation-resistant compartment. 
Histopathological analysis of the CNS revealed extensive immune cell 
infiltrates, microgliosis and demyelination in all experimental groups. Substantial 
presence of granulocytes was observed in all groups apart from WT>WT. The 
analysis did not reveal any particular difference in the intensity of inflammation 
between the spinal cord and the brain of each group. Also, the analysis did not 
support a notion that some groups showed higher extent of inflammation than 
the others - the specimens with highest scores for intensity of inflammation were 
found in all groups (Figure 8). 
Overall, the results suggest that the deficiency of IFNγ signaling in the 
radiation-resistant cell compartment contributes more to the occurrence of 
atypical symptoms than the deficiency in the hematopoietic compartment. The 
fact that the composition of immune cells infiltrating the CNS does not fully 
conform to this line of reasoning raises the question of whether there is a causal 
link between these two sets of features or to they just happen to correlate most of 
the time for reasons not yet understood. Some authors suggest there is no causal 
link between the two (Kroenke et al., 2010; Lee et al., 2012). 
Following the same line of reasoning as Kroenke et al. and Lee at al., we 
decided that greater weight should be assigned to correlated clinical features, 
rather than the composition of the cells infiltrating the CNS since atypical clinical 
course has been shown to reflect differential localization of dominant site of CNS 
tissue damage. As we saw similar clinical features in the WT>gR and in the 
gR>gR control group, we concluded that the disruption of the IFNγ signaling in a 
certain radiation-resistant cell type might be responsible for development of 
atypical EAE. 
In order to investigate which cell type is is involved in the process, we 
decided to use a genetic system for cell-specific ablation of IFNγ signaling by 
targeting Cre-mediated disruption of the fingr2 gene to different radiation-
resistant cell types that might play a role during EAE. 
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Figure 8. Histological analysis of the brain and spinal cord of bone marrow chimeric mice at the
peak of EAE.
Mice were sacrificed at the peak of disease and transcardially perfused with PBS, followed by
formalin. CNS was harvested, embedded in paraffine and stained with hematoxylin and eosin, Luxol
fast blue-periodic acid Schiff and Iba-1. First co lumn 10x magnification. Columns 2-4 60x
magnification. Representative pictures of 2 independent experiments are shown (32 mice).
THE EFFECTS OF INTERFERON GAMMA DEFICIENCY ON THE AUTOIMMUNE INFLAMMATION OF THE CENTRAL NERVOUS SYSTEM 
39 
 
The conditional IFNgR2 genetic system is a valid tool to study cell-
specific ablation of IFNγ signaling 
The group of Werner Muller from the University of Manchester has 
generated a mouse strain where the exon 4 of the ifngr2 gene is flanked by loxP 
sites (Ifngr2tm1Hzi, unpublished). Breeding this mouse strain to strains with cell-
specific expression of the Cre recombinase will allow the abrogation of IFNγ 
signaling in that particular cell type(s). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To test if the mentioned strain indeed behaves as expected, we crossed it 
to a mouse strain that ubiquitously expresses the Cre-recombinase, namely 
deleter-cre (Schwenk et al., 1995), effectively producing a complete IFNγ-receptor 
knock out, subsequently termed IFNGR2-KO mice. 
 Upon active EAE induction, this newly generated mouse strain showed 
atypical disease symptoms, completely phenocopying the clinical features of the 
IFNγ- and IFNγ receptor-deficient mice (Figure 9a). Based on just a few animals 
examined, an increase of neutrophils among the immune cells infiltrating the 
CNS compared to wt mice was not observed (data not shown). It should also be 
noted that these mice seemed to have a slightly milder course of atypical EAE, 
Figure 9. Examination of IFNGR2-KO mice
Mice were immunized with MOG35-55 in CFA
and disease progression observed. Pooled data
from 2 independent experiments and 54
examined mice is shown in (a). Representative
figures from 2 independent experiments shown
in b-e. Prevalence of atypical EAE among
IFNGR2-KO mice (a). IFNγ responsiveness
measured as phosphorylation of STAT1 upon
IFNγ stimulation of splenocytes (red
histogram). Gated on CD11b+ cells.
Unstimulated cells in gray. IFNGR2-KO mice
(b), IFNGR2KO/WT mice (c) and WT mice (d).
Comparison of IFNγ responsiveness of WT
(blue histogram) and IFNGR2KO/WT mice (red
histogram) (e)
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never reaching scores of 4 or 5, as it was sporadically the case with IFNGR1-KO 
mice. Additionally, as the mice were sacrificed at the late stage of the disease (25 
days after immunization), unlike the GKO and IFNGR1 KO mice, taken earlier, 
this could be a potential explanation for the absence of neutrophilia in the 
inflamed CNS (Abromson-Leeman et al., 2004). Whether this really was the case 
remains to be established in subsequent experiments investigating infiltrates at 
different time points in GKO, IFNGR1-KO and IFNGR2-KO mice.  
Stimulation of splenic myeloid cells, previously shown to express 
functional IFNγ receptor at high levels in a steady state in humans (Bernabei et 
al., 2001) and mice (Heng et al., 2008), with recombinant mouse IFNγ revealed 
complete absence of IFNγ signaling in IFNGR2-KO mice, confirming the genetic 
makeup of the newly created strain (Figure 9b). The heterozygous animals, still 
having one non-recombined (wt) ifngr2 locus showed a uniform pSTAT1 
staining, with just slightly lower overall staining intensity compared to the WT 
mice (Figure 9c and 9e). For practical purposes, it suggests that the heterozygous 
mice show equal response to IFNγ stimulation as wt mice. Overall, these results 
suggest that the ifngr2 flox genetic system is functional and represents an 
appropriate tool for further studying the cell-specific deletion of the ifngr2 gene.  
Disruption of IFNγ signaling in neurons, astrocytes and 
oligodendrocytes is insufficient to drive  atypical EAE 
Some previous reports suggested, based on adoptive transfer experiments 
where WT cells were transferred into IFNγ-receptor-deficient hosts, that the 
atypical EAE is very likely mediated by some cell type(s) other than the 
adoptively transferred CD4 T cells (Lees et al., 2008). Even older reports imply 
that inability of a recipient mouse to sense IFNγ causes a more severe form of 
EAE (Willenborg et al., 1996). At the same time, our own results obtained from 
BM chimeras suggested that the absence of IFNγ signaling in the radiation-
resistant cell compartment is likely contributing more to the atypical phenotype 
than the same defect in hematopoietic cells. Also, immunohistological 
examination of the inflamed CNS in WT mice showed that almost all cell types of 
the CNS are responsive to IFNγ during autoimmune inflammation. This led us to 
hypothesize that the inability of the invaded tissue (CNS) to respond to the IFNγ 
mainly secreted by the invading CD4 T cells could be a initiating event for 
atypical EAE. We have decided to test the hypothesis by selectively disrupting 
the ifngr2 gene in one or more cell types of the CNS. 
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The nestin-Cre mouse line (Tg(Nes-cre)1Kag) carries the Cre recombinase 
gene under the control of the nestin promoter and enhancer, which specifically 
directs expression in neural precursor cells (Isaka et al., 1999; Zimmerman et al., 
1994). In situ hybridization analysis demonstrated that the Cre recombinase is 
specifically expressed in the developing nervous system. The expression was 
clearly observed in the peripheral nervous system such as the dorsal root ganglia 
and in the ventricular zone of the developing central nervous system such as the 
telencephalon and the spinal cord (Isaka et al., 1999). 
We bred the nestin-Cre strain to Ifngr2tm1Hzi mice, generating a new strain 
that lacks a functional IFNγ receptor on the surface of brain cells descending 
from neural precursor cells - neurons and glia cells (apart from microglia, which 
originates from primitive, yolk sac macrophages (Geissmann et al., 2010; Schulz 
et al., 2012; Yona et al., 2013)). The efficiency and specificity of Cre-mediated 
recombination at the Ifngr2 locus in neurons and/or glia cells was not confirmed 
(see Discussion for more details). 
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 A total of 6 independent EAE experiments (active EAE induction) were 
performed, with somewhat inconsistent results in terms of the occurrence of 
atypical EAE. In 4 out of 6 experiments, active EAE induction was followed with 
classical disease symptoms of comparable magnitude in both experimental 
groups, suggesting that the deficiency of IFNγ signaling in neurons and 
macroglia (a collective term used for astrocytes and oligodendrocytes) is not 
sufficient to drive atypical disease (Figure 10a). The notion was further backed up 
with the analysis of the composition of immune cell infiltrates in the CNS of 
diseased animals. We found no significant difference among the experimental 
groups and none of them displayed an increased proportion of neutrophils or 
absence of moDCs, features usually observed during atypical EAE in IFNγ- and 
IFNγR-deficient mice (Figure 10b and 10c). 
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The remaining two independent experiments showed, however, the 
occurrence of atypical EAE (data not shown) that did not correlate with the 
genotype. Fischer's exact test reported no statistical difference between the Cre+ 
and Cre- mice (data not shown). The analysis of immune cell infiltrates showed 
resemblance to the composition normally found during prototypical atypical 
EAE seen in IFNγ- or IFNγ receptor-deficient mice (low proportion of monocyte-
derived DCs and elevated proportion of neutrophils, Figure 11a and 11b). A k-
means clustering analysis defined two clusters of variables, where genotype was 
not the main grouping variable but rather the feature of EAE. That means 
increased numbers of neutrophils were found in mice with atypical EAE 
irrespective of the genotype. When grouping the results obtained from analysis 
of composition of cells infiltrating the CNS according to this variable (Figure 11c 
and 11d), the overall variation within the groups was minimized, suggesting a 
stronger correlation of immune cell composition to the disease phenotype, not 
the animal genotype. Based on our data, previous published reports and our 
unpublished observations, we have a reason to suspect a germline deletion of the 
Ifngr2 gene in these mice which will be discussed in more detail later in the 
Discussion. 
Overall, we concluded that disruption of IFNγ signaling on neurons and 
macroglia is insufficient to drive atypical EAE. 
Cell-specific disruption of IFNγ signaling in microglial cells is insufficient 
to drive atypical EAE 
The nestin-Cre strain directs Cre-recombinase activity in almost the entire 
brain apart from microglia cells. Our previous results suggest that microglia cells 
are responsive to IFNγ during neuroinflammation, making them a cell type with 
a potential role in atypical EAE. To investigate the effects of disrupted IFNγ 
signaling in microglia on EAE disease course, we have used the CX3CR1CreER 
mouse strain. It harbors the targeted insertion of a conditional active Cre-ERT2 
recombinase into the Cx3cr1 locus, replacing the coding exon of Cx3cr1. Upon 
administration of tamoxifen more than 95% of both brain and spinal cord 
microglia were shown to express the reporter gene construct. Thus, when crossed 
to mice harboring “floxed” candidate genes, the system can be utilized to delete 
or express specific genes in CX3CR1+ microglia (Yona et al., 2013). Certain 
lymphocyte and myeloid subsets also express CX3CR1, making them a target of 
CreER-mediated genetic rearrangement. However, most peripheral myeloid cells 
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that undergo Cre activation and rearrangements have a limited half-life and are 
continuously replaced by BM-derived cells. Genetic modifications are thus 
progressively lost with time in these populations. In contrast, the resident 
microglia pool which self-renews without further input from the BM retains once 
introduced gene modifications throughout the life of the organism (Wolf et al., 
2013). 
We bred the CX3CR1CreER mice to the Ifngr2tm1Hzi mice, generating a new 
strain that, upon tamoxifen treatment, undergoes Cre-mediated recombination 
and renders microglia and a subset of circulating leukocytes unresponsive to 
IFNγ stimulus. After allowing for the repopulation of targeted circulatory cells 
from their respective BM precursors, the mouse strain remains with only 
microglia not having a functional IFNγ receptor anymore. The efficiency of Cre-
mediated disruption of the "floxed" locus in microglial cells was confirmed using 
the genetic reporter system (EYFP expression following Cre-mediated 
recombination event) and was found to be around 71% (average of 5 different 
mice, Figure 12c). 
 Active EAE induction in the newly created strain results in the typical 
disease progression without observing any enduring atypical symptoms that 
correlated with the genotype. The disease course and overall severity do not 
differ among the two experimental groups (CX3CR1CreER+ and CX3CR1CreER-). 
Additionally, the cellular composition of the immune infiltrates in the CNS at the 
peak of EAE does not differ among the two experimental groups and resembles 
the one found in WT mice rather than the one found in complete IFNγ receptor-
deficient mice. Taken together, the results indicate that the disruption of IFNγ 
signaling in microglial cells alone is insufficient to drive atypical disease course 
as seen in complete IFNγ receptor-deficient or IFNγ-deficient mice. 
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Cell-specific disruption of IFNγ signaling in endothelial cells is 
insufficient to drive atypical EAE 
 The disruption of the blood-brain barrier (BBB) has been shown to 
precede the onset of clinical symptoms in EAE and the sites of disruption 
correlate with the sites of inflammatory cell accumulation (Bennett et al., 2010). 
Since endothelial cells make a critical component of BBB and they have been also 
shown to respond to IFNγ stimulation (Schroder et al., 2004), we sought to 
investigate whether disruption of IFNγ signaling in endothelial cells plays a role 
in driving atypical EAE. To this end, we have used the VE-Cadherin-Cre mouse 
strain, which harbors a transgene that contains the Cre recombinase coding 
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Figure 12. Analysis of CX3CR1-CreERt2 x Ifngr2 floxmice
Cre expression was induced according to the Methods section. Mice were immunized with MOG35-55 in
CFA and disease progression observed. Representative of 5 independent experiments (44 mice) shown
in (a). Pooled data from 2 independent experiments (30 mice) shown in (d). Representative figure (5
mice) shown in (c).
Clinical disease course (a). Prevalence of atypcial EAE (b) Efficiency of CreERt2 expression in
microglia following Tamoxifen induction, measured as percentage of cells expressing the reporter gene
construct (flox-stop-flox EYFP). In red are CreERT2+ and in gray CreERT2- microglia (c).
Composition of immune cells infiltrating the CNS at the peak of disease (d).
a b
c d
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region fused to a regulatory region of the VE-Cadherin promoter (Alva et al., 
2006). Vascular endothelial cadherin (VECadherin), also known as CD144 and 
cadherin-5, is a transmembrane protein involved in endothelial homotypic cell 
adhesion (Lampugnani et al., 1995). During initial characterization, Cre 
expression was reported to increase throughout embryonic development, starting 
as early as E7.5 and reaching close to full penetrance (96.4%) by E14.5. It was 
equally penetrant in arteries, veins and capillaries and was specific for 
endothelial cells. The ectopic expression of the reporter construct was not found, 
nor expression of the reporter in Cre-negative mice or variations in the pattern of 
Cre activity when the lines were crossed into C57Bl/6 mice for 8 generations(Alva 
et al., 2006). In adult mice, reporter expression was also found in about half of all 
circulating blood cells and in hematopoietic organs, with approximately 50% of 
all hematopoietic lineages in adult bone marrow expressing the reporter (Alva et 
al., 2006). 
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 We bred the VE-Cadherin-Cre strain to Ifngr2tm1Hzi mice, generating a new 
strain that lacks a functional IFNγ receptor on the surface of endothelial cells and 
a subset of blood-circulating leukocytes. The efficiency of Cre-mediated 
recombination at the Ifngr2 locus in endothelial cells was confirmed using the in 
vivo assay of ICAM-1 upregulation in a tumor microenvironment and was shown 
to be complete (Sara Burkhard, unpublished). Active EAE induction in this newly 
created strain results in the classic disease progression without observing any 
atypical symptoms. The disease course and overall severity do not differ among 
the two experimental groups (TgVE-Cadherin-Cre+ and TgVE-Cadherin-Cre-). The cellular 
composition of the immune infiltrates in the CNS at the peak of disease does not 
differ among the two experimental groups and resembles the one found in WT 
mice rather than the one found in complete IFNγ receptor-deficient mice (Figure 
13). Additionally, both experimental groups show no difference in the 
composition of immune cell infiltrates in the brain and brain stem compared to 
the spinal cord and both sites show the same ratio of infiltrating cells to 
microglia, suggesting the same extent of immune cell invasion of both sites (data 
not shown). Taken together, the results indicate that the ablation of IFNγ receptor 
from the surface of endothelial cells alone is insufficient to drive atypical disease 
course as seen in a complete IFNγ receptor-deficient or IFNγ-deficient mice. 
Cell-specific disruption of IFNγ signaling in T cells is insufficient to drive 
atypical EAE 
 Since we were able to show that disruption of IFNγ signaling in almost all 
the radiation-resistant cells of the CNS is insufficient to drive atypical EAE on 
their own, we decided to investigate a few additional cell compartments. 
Namely, some cell types of the immune system seem to be somewhat resistant to 
the irradiation regime we used previously in generating bone marrow chimeric 
mice. It has been shown by others (Iva Lelios and Melanie Greter, personal 
communication) that, in some cases, the CD4 T cell compartment shows only a 
50% reconstitution efficiency following lethal irradiation and transfer of 
congeneic bone marrow, despite the fact that other cell compartments showed a 
100% reconstitution efficiency. To investigate whether disruption of IFNγ 
signaling in T cells plays a role in driving atypical EAE, we used the CD4-Cre 
mouse strain that harbors a transgene that contains the CD4 enhancer, promoter 
and silencer sequence driving the expression of the Cre recombinase gene. Cre 
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expression reportedly results in >99% deletion of loxP flanked genes by the 
double-positive stage of T-cell development (Lee et al., 2001). 
We bred CD4-Cre mice to Ifngr2tm1Hzi mice, thus generating a new strain 
that lacks a  functional IFNγ receptor on the surface of T cells. The efficiency of 
Cre-mediated recombination at the Ifngr2 locus was confirmed using the in vitro 
assay of IFNγ responsiveness of splenic CD4 T cells and was shown to be >99% 
(Figure 14c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Active EAE induction in the newly created strain results in the typical 
disease progression without observing any enduring atypical symptoms that 
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Figure 14. Analysis of CD4-Cre x Ifngr2 flox mice
Mice were immunized with MOG35-55 in CFA and disease progression observed. Representative of 3
independent experiments (30 mice) shown in (a). Pooled data from 2 independent experiments (20
mice) shown in (d).
Clinical disease course (a). Prevalence of atypical EAE in CD4-Cre+ and CD4-Cre- mice (b).
Efficiency of Cre-mediated disruption of Ifngr2 gene directly estimated through ex vivo stimulation of
splenic T cells with IFNγ (in red), followed by detection of phosphorylated STAT1 (c). Unstimulated
splenic T cells in gray. St imulated IFNGR1-KO splen ic T cells in blue. Composition of the immune
cells infiltrating the CNS at the peak of disease (d).
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correlated to the animal genotype (Figure 14b). The disease course and overall 
severity do not differ among the two experimental groups (Tg(CD4-Cre)+ and 
Tg(CD4-Cre)-) and resemble the ones of the WT mouse strain (Figure 14a). 
Additionally, the cellular composition of the immune infiltrates in the CNS at the 
peak of disease does not differ among the two experimental groups and 
resembles the one found in WT mice rather than the one found in complete IFNγ 
receptor-deficient mice (Figure 14d). Taken together, the results indicate that the 
ablation of IFNγ receptor from the surface of T cells alone is insufficient to drive 
atypical disease course as seen in a complete IFNγ receptor-deficient or IFNγ-
deficient mice.  
Cell-specific disruption of IFNγ signaling in neutrophils and a subset of 
myeloid cells drives atypical EAE 
Since all attempts made to this point have failed to induce atypical EAE by 
disrupting IFNγ signaling in various cell types that are important during EAE 
and also have been shown to respond to IFNγ in vivo during neuroinflammation, 
we have decided to target the disruption of IFNγ signaling to the two cell types 
that have so far shown differential abundance among the cells infiltrating the 
CNS during classical and atypical EAE - neutrophils and moDC. Probably the 
most appropriate tool for this is the LysM-Cre mouse strain. It has a targeting 
construct encoding for the Cre-recombinase introduced into the endogenous 
ATG-start site within the first exon of the lysozyme M gene, driving its specific 
expression in monocyte/macrophages and neutrophils (Clausen et al., 1999). 
 During initial characterization, the Cre expression was reported in 95% of 
F4/80+ peritoneal macrophages and 99% of peritoneal neutrophils. Lymph node T 
cells and splenic B cells were shown not to undergo significant Cre-mediated 
gene rearrangement (2%). Around 16% of splenic DCs showed evidence of Cre 
activity (Clausen et al., 1999). Subsequently, activity of LysM-Cre was also shown 
in hematopoietic stem cells, allowing for Cre-mediated genetic rearrangement 
being detected in myelomonocytic cells and subset of B and T cells. In extreme 
cases, the entire hematopoietic compartment exhibited Cre-mediated reporter 
gene expression (Ye et al., 2003). A different group of authors reported LysM-
Cre-mediated reporter gene (EYFP) expression in 55% of Ly-6Chi monocytes and 
75% of Ly-6Clo monocytes. However, they suggest that there is no inherent 
difference among the EYFP- and EYFP+ monocytes. The difference is rather 
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caused by the stochastic failure of lysozyme promoter or Cre-mediated excision 
(Jakubzick et al., 2008). 
We bred the LysM-Cre strain to Ifngr2tm1Hzi mice, generating a new mouse 
strain with disrupted IFNγ signaling in neutrophils and a subset of 
myelomonocytic cells. 
Active EAE induction in this newly created strain results in consistent 
occurrence of atypical EAE with average prevalence of 48% (10 out of 21 mice in 
total, Figure 15a). The control group has a prevalence of 8% (2 out of 26 mice in 
total). According to the Fischer's exact test, this difference is statistically 
significant with a P value of 0.0026. The course of atypical EAE in LysM-Cre+ 
mice is slightly less severe (never reaching the scores of 4 and 5) compared to the 
IFNGR1-KO mice and tends to revert to intensive classical EAE (score of 2.5 and 
higher) after 2-4 days. 
The immune cells infiltrating the CNS are not dominated by neutrophils 
and the moDCs are present in much higher proportion compared to the IFNGR1-
KO controls (Figure 15b). No changes in proportions of any of the cell 
populations examined so far have been found. Cell-specific ablation of IFNγR on 
neutrophils and subset of myeloid cells seems to be sufficient to drive atypical 
EAE. 
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Since multiple reports showed vastly different activity of Cre recombinase 
driven by the lysozyme M promoter, we also investigated whether a different 
extent of Cre activity in different cell populations of Cre+ mice could account for 
the occurrence of atypical EAE. 
 We assessed the efficiency of Cre-mediated recombination by flow 
cytometric analysis of pSTAT1. To achieve maximum reproducibility of the 
analysis and avoid bias in gating, an Overton subtraction algorithm was used to 
calculate the proportion of cells that have responded to IFNγ stimulation ex vivo 
(Overton, 1988) Depending on the shape of the histogram (unimodal vs. 
bimodal), the algorithm reports statistic that cannot be used as a measure of 
efficiency of Cre-mediated recombination and is different to what would be 
calculated by other methods. For instance, the efficiency of Cre-mediated 
recombination in neutrophils has been reported to be almost 100%, and this is 
what one also captures by eye when looking at the pSTAT1 staining histograms 
of appropriate mice (Figure 17). The Overton subtraction algorithm, however, 
reports 20% of neutrophils still being able to respond to IFNγ, which is most 
likely an overestimation and is due to the different frequency of cells away from 
the mode of the distribution. At the same time, monocytes in Cre- mice show 
almost 100% responsiveness to IFNγ stimulation, as one would expect. The 
algorithm reports, however, only 70% of responding cells, which is an 
underestimation and is due to the overlap of pSTAT1 histograms of stimulated 
and unstimulated cells (Figure 17). Taken together, the values reported by the 
Overton subtraction algorithm should be used only for comparison among each 
other and should not be used to infer efficiencies of Cre-mediated recombination 
intended for comparison to readouts of other methods (reporter gene expression, 
qRT-PCR, Western Blot or similar). That said, neutrophils show the most 
extensive Cre-mediated gene rearrangement, compared to other myeloid 
populations showing a lower and more varying extent (Figure 16a). The 
interpretation of the data is made complicated by the fact that MHC II expression 
is used as a defining surface marker for describing certain subset of cells 
(monocyte-derived DCs, for instance) but the surface expression of the molecule 
only happens in the response to the IFNγ stimulation. It is, therefore, conceivable 
that the investigation of IFNγ responsiveness of moDCs would be biased against 
the cells undergoing the Cre-mediated recombination, since they would most 
likely not be included in the defining gate. Nevertheless, there seems to be no 
difference between the Cre+ mice showing atypical or classical EAE in terms of 
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Cre-mediated recombination among the different cell subsets examined (Figure 
16b). In other words, the observation of a LysM-Cre+ mouse having atypical EAE 
does not correlate to a different efficiency of Cre-mediated recombination in 
examined subsets of myeloid cells. 
  
Figure 17. Analysis of the efficiency of Cre-mediated Ifngr2 disruption accorss multiple cell types
Representative figures from the dataset in Figure 16.
pSTAT1
pSTAT1
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Are neutrophils the main drivers of atypical EAE? 
So far the role of neutrophils in atypical EAE has not been established. The 
impressive amount of neutrophils found in CNS lesions of IFNγ-KO and 
IFNγR1-KO mice correlates with the occurrence of atypical EAE, but some have 
suggested that there is no causal link among the two (Kroenke et al., 2010; Lee et 
al., 2012). There are reports claiming that neutrophils are non-redundant for EAE 
in general, and their depletion leads to complete EAE resistance (Kroenke et al., 
2010; McColl et al., 1998). However, McColl et al. report that this requirement is 
not so strict in passive EAE, where neutrophil depletion results only in milder 
EAE course. The very early  work on mice deficient in IFNγ signaling almost 
never reported occurrence of atypical EAE. Instead, there has been a consensus 
that EAE in these mice is exacerbated (Chu et al., 2000; Ferber et al., 1996). This 
leaves a possibility that atypical EAE was potentially misinterpreted as 
exacerbated form of classical EAE. Therefore, it is worthy to reevaluate the work 
of McColl et al. and see if neutrophil depletion during passive EAE results in 
modulation of atypical EAE, which might shed light on the role neutrophils play, 
if any. 
 We have set up the passive EAE experiment in a way that was previously 
reported to induce atypical EAE - transferring IFNγ-deficient cells into WT 
recipients. Neutrophils were depleted by repeated administration of the anti-
Ly6G antibody (1A8 clone), starting 1 day before the adoptive transfer and 
administering the same dose (200 µg per mouse) every fourth day. Depleting 
neutrophils in mice either not transferred with encephalitogenic cells or 
transferred but inspected prior to the disease onset has proven to be effective 
(complete absence of neutrophils, Figure 18b and 18c). However, by the time 
mice started to develop EAE, depletion was not effective anymore and there was 
no difference in the proportion of  neutrophils among anti-Ly6G- and isotype-
treated group (Figure 19b). A potential caveat is the fact that neutrophils in anti-
Ly6G treated mice stained less bright for Ly6G (now with Gr-1 isotype, Figure 
16a) and evaluating depletion based on gates set on isotype-treated mice would 
be misleading and would result in a report showing complete absence of 
neutrophils. However, the light scatter profile suggests that these cells are, most 
likely, indeed neutrophils. The passive EAE was fully penetrant and resulted in 
severe EAE (Figure 18a). The composition of immune cells infiltrating the CNS 
was indistinguishable between the two groups (Figure 19c). However, there was 
no consistent occurrence of atypical EAE in any of the groups and, therefore, no 
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conclusions about the role of neutrophils in atypical EAE could be drawn. In the 
future, this experiment needs to be repeated using a different approach. 
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neutrophil-depleted recipients
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neutrophil-deplet ing 1A8 antibody or isotype
control and adoptively transferred with leukocytes
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Figure 19. Adoptive transfer EAE in neutrophil-depleted recipients
Monitoring depletion of neutrophils from peripheral blood at the onset of EAE. (a). Proportion of neutrophils
in peripheral blood of mice treated with the depleting antibody (clone 1A8) or isotype control at the disease
onset (b). Composition of immune cells infiltrating the CNS at the peak of disease (c).
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Discussion 
The atypical EAE observed in mice deficient in IFNγ signaling is not 
unique to that particular experimental system - it has also been reported in 
various other systems, where a certain combination of mouse strain and 
immunizing agent was used (Greer et al., 1996; Muller et al., 2000). But, the genetic 
system of IFNγ deficiency likely provides the most precisely defined system, 
with the fewest amount of variables that affect the outcome. This is convenient 
since it clearly suggests the starting point for dissecting the complex biological 
system and asking a question - what is the causal link between the IFNγ 
deficiency and occurrence of atypical EAE? This is a somewhat simplified view 
and is not without caveats. The obvious one is - how general this observation is? 
In our hands, deficiency of IFNγ signaling has consistently resulted in occurrence 
of atypical EAE. However, as with EAE in general, it is not clear why animals of 
the "same" genetic makeup and maintained in the "same" environment 
sometimes succumb to the atypical disease while sometimes they do not. The 
older reports that sought to investigate the impact of IFNγ deficiency on 
autoimmune inflammation of the CNS reported exacerbated EAE, rather than 
atypical one (Chu et al., 2000; Ferber et al., 1996). One could argue that the more 
exacerbated EAE could have been a misclassified case of atypical EAE, since the 
atypical EAE has not been well documented back then. However, some of the 
more recent work also reports exclusively classical EAE in IFNγ-deficient mice 
(Wang, 2006). In my personal view, investigating atypical EAE on its own is 
valuable since it addresses one of the features that is often subject of criticism of 
EAE as a model for MS, in that it shows an unexplained bias of inflammation in 
the spinal cord over the brain, which is not the case in human disorders. Since 
atypical EAE shows no bias of that kind, it might provide additional insight into 
the basic mechanisms of autoimmune inflammation of the CNS. 
IFNγ plays many different roles in the immune system (Boehm et al., 1997; 
Schroder et al., 2004). It should not come as a surprise then, that it was also 
implicated in autoimmune inflammation of the CNS. Big body of circumstantial 
evidence exists that links IFNγ and inflammation in MS and EAE. Many of the 
hallmarks of autoimmune inflammation are consistent with the reported effects 
of IFNγ - increased MHC II expression, macrophage activation, increased 
expression of adhesion molecules on the BBB (Olsson, 1992) and reactive gliosis. It 
is also detected in active MS lesions (Traugott and Lebon, 1988a, 1988b) and 
increased numbers of IFNγ-secreted T cells were detected in the CSF of MS 
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patients (Olsson et al., 1990). In EAE, the disease can be elicited in naive mice by 
adoptive transfer of IFNγ-producing T cells and animals with severe EAE show 
higher amounts of IFNγ mRNA in the CNS compared to the mice with mild EAE 
(Renno et al., 1994; Zamvil and Steinman, 1990). There have been only few clinical 
trials performed aimed at directly investigating the role of IFNγ in MS. In 1987 
Panitch et al. reported that 7 out of 18 RRMS patients receiving IFNγ i.v. 
experienced exacerbations during the treatment period (Panitch et al., 1987), 
suggesting a disease promoting role for IFNγ. Similar conclusions were reached 
by another trial performed by Skurkovich et al., where they reported that 
treatment with antibodies against IFNγ was beneficial in secondary progressive 
MS (Skurkovich et al., 2001). In EAE, there are reports suggesting both disease-
limiting and disease-promoting role for IFNγ. However, the work that involved 
either physiologically relevant interventions or utilized genetic deficiency 
systems mostly reported a disease limiting role, which is in contrast to 
conclusions drawn from human medical trials (Sanvito et al., 2010). 
We have shown that disruption of IFNγ signaling in mice susceptible to 
EAE induction leads to the occurrence of atypical EAE which is characterized by 
dominant tissue damage in the cerebellum, rather than the spinal cord. IL17A is 
dispensable for this process. The composition of immune cells infiltrating the 
CNS does not necessarily correlate with the type of EAE and, hence, the 
dominant site of CNS tissue damage. There have been some reports implicating 
chemokines as the decisive factor determining the site of dominant CNS tissue 
damage (Abromson-Leeman et al., 2004; Tran et al., 2000). The conclusions drawn 
by the authors, if appropriate and applicable across different mouse strains, 
would suggest that the cell type responding to the lack of IFNγ signaling by 
producing a different set of chemokines would have to be present at the site of 
inflammation since, by definition, chemokines act only on short distances. The 
bone marrow chimera experiments we performed suggested that it is the inability 
of the invaded tissue to respond to the IFNγ that allows for the occurrence of 
atypical EAE, much more so than disrupted signaling in the invading cells. The 
same concept was also put forward by other authors (Lee et al., 2012; Lees et al., 
2008). Taken together, it seemed reasonable to disrupt IFNγ signaling in the cells 
of the invaded tissue first. 
We have examined all the cell types present in the CNS and found that, 
when examined separately, disruption of IFNγ signaling in them is insufficient to 
induce atypical EAE. Notably, some of the Cre strains used had even broader 
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activity and have targeted disruption of IFNγ signaling to additional cell types 
then the ones they were primarily intended for. For instance, it has been reported 
and we have also observed that the VE-Cadherin-Cre mouse strain shows 
recombinase activity in roughly 50% of circulating leukocytes, in addition to the 
vascular endothelium. This suggests that even broader disruption of IFNγ 
signaling than initially expected was still insufficient to drive atypical EAE. 
A special case depicts the nestin-Cre x Ifngr2 flox strain we have created 
and examined in several experiments. In 2 independent experiments these mice 
showed atypical EAE. However, the occurrence of it did not correlate with the 
genotype as there was no statistical difference between the 2 groups, with or 
without the Cre-recombinase present. When the total of 6 independent 
experiments was examined together, these 2 "unusual" experiments did not affect 
the outcome of analysis - expectedly, there was no statistical significance in the 
difference observed between the two groups. Previous publications suggested 
that nestin-Cre transgene construct shows a tendency to generate germline 
deletion (Bates et al., 1999; Buchholz et al., 2000; Dubois et al., 2006). There are 
multiple nestin-Cre strains available. Although this particular aspect was not 
extensively investigated for the strain we used, it was clearly shown by the strain 
creator that the Cre recombinase was active in the CNS during embryonic 
development. Although recombinase activity outside desired tissue is 
unfortunate and generally compounds the interpretation of results, in our 
situation this was not the case. As long as the CNS was the main site of Cre 
recombinase activity (which is the point seemingly confirmed by a multitude of 
publications) our conclusions about disrupted IFNγ signaling in the CNS and 
atypical EAE are valid. Unfortunately, we were not able to investigate the 
expression patterns of our strain in greater detail. Following an isolated hygienic 
incident, the majority of the mice of this strain were sacrificed and the whole 
colony was re-established from a single mouse carrying the nestin-Cre transgene. 
Obviously, this presents a serious bottleneck in the population genetics and it 
was later confirmed that one of the founding animals had undergone a germline 
deletion of the floxed Ifngr2 gene, resulting in mice fully deficient in Ifngr2 gene 
regardless of the presence of the Cre transgene. We have every reason to suspect 
that similar events were also taking place in the original mouse colony, but with 
low frequency and masked to some extent since the offspring of multiple 
breeding pairs was randomly mixed. In our view, this represents the most 
plausible explanation for the results obtained from two aberrant experiments and 
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is the reason why the extent of Cre-mediated recombination at the Ifngr2 locus 
was so far not independently confirmed by us. As soon as a proper colony status 
is re-established, this will be performed. Until then, the total number of nestin-
Cre mice examined by us and previous published findings leave little doubt in 
the conclusions we have drawn. 
In an attempt to reconcile the reports suggesting a role of chemokines and 
considering the possibility that our bone marrow chimera experiments were 
misleading,  we decided to disrupt IFNγ signaling in other cell types invading 
the CNS during autoimmune inflammation. Our experiments with bone marrow 
chimeras suggested a more dominant role of IFNγ signaling in radiation-resistant 
cell type(s) than in radiation-sensitive one(s). However, it is possible that the 
cytokine storm following the irradiation process and incomplete engraftment of 
the transferred bone marrow masked the true nature of the initiating event in 
atypical EAE, leading us to too narrow conclusions. 
We were able to show that disrupted signaling in T cells is insufficient to 
promote atypical EAE. The same was the case for mice with CD11c promoter-
driven Cre expression, but it was later shown that this tool fails short in 
disrupting the IFNγ signaling in CD11c+ cells of the inflamed brain, probably due 
to different kinetics of CD11c and IFNγR2 regulation (Andrew Croxford, 
unpublished observations). Surprisingly, we found that lysozyme M (LysM) 
promoter-driven Cre expression and resulting disruption of IFNγ signaling in 
neutrophils and subset of myeloid cells is sufficient to induce atypical EAE. The 
genetic system where the LysM promoter drives Cre expression allows for almost 
complete IFNγ signaling disruption in neutrophils and, most probably, 
macrophages (Clausen et al., 1999; Jakubzick et al., 2008; Ye et al., 2003), while the 
remaining cell types activating the locus are targeted to a various extent. In mice 
with autoimmune inflammation of the CNS, the only other "remaining cell type" 
present at the site of inflammation is monocyte-derived dendritic cells (moDCs). 
To best of our knowledge, the deficiency of IFNγ signaling in moDCs has 
not yet been reported to play a role in atypical EAE. On the other hand, the 
moDCs have been implicated as important cell type in EAE in general (Mildner et 
al., 2009). Their putative role in allowing for the occurrence of atypical EAE is 
currently the matter of intense work by the author. On the other hand, 
neutrophils have been investigated by us and others as a potential cell type that 
plays a critical role in atypical EAE. While some groups (Abromson-Leeman et al., 
2004; Kroenke et al., 2010; Lees et al., 2008; Wensky et al., 2005) reported that 
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neutrophils are associated with CNS lesions giving rise to atypical EAE, there is a 
number of reports showing that an extensive amount of neutrophils at the site of 
CNS inflammation does not necessarily induce atypical EAE (Kroenke et al., 2010; 
Lee et al., 2012; Tran et al., 2000). McColl et al. and Kroenke et al. reported that 
depleting neutrophils renders mice resistant to EAE induction. However, since 
McColl et al. used an anti-Gr-1 depleting antibody which is not specific for 
neutrophils, it is likely that they have also depleted some additional myeloid cell 
types. Kroenke et al. claimed successful neutrophil depletion and sparing of other 
leukocyte subsets using the CXCR2 anti-serum. However, since those mice were 
resistant to EAE induction, it was not possible to examine the role of neutrophils 
in atypical EAE. However, McColl et al reported that adoptive transfer EAE is 
less dependent on neutrophils and upon their depletion, mice show only slightly 
lower disease severity. This opens a possibility to investigate their role during 
atypical EAE. Our attempts so far have failed to provide concrete clues as we 
have been unable to maintain the depletion status of neutrophils once the mice 
started developing EAE symptoms. The experiments are underway to tackle this 
problem using a different approach. 
Regarding the potential mechanism of action, Chu et al. suggested that the 
exacerbated EAE seen in IFNγ-deficient mice might be caused by the excessive 
amounts of CD4 T cells infiltrating the CNS as a consequence of their more 
intense proliferation and increased resistance to apoptosis in the absence of IFNγ 
signaling (Chu et al., 2000). These are interesting conclusions since the work of 
others suggests that in the absence of IFNγ-induced phosphorylation, STAT1 
drives constitutive transcription of genes such as caspases (Kumar et al., 1997; Lee 
et al., 2000), which would act opposite to the observed findings. With regards to 
our data, we never noticed 10-16 fold increase in number of CD4 T cells during 
atypical EAE in IFNγ deficient mice, as reported by Chu et al. In fact, the 
proportions of CD4 T cells mostly remained the same, regardless of the type of 
EAE. So, the sheer number of infiltrating CD4 T cells doesn't seem to be required 
for the development of atypical EAE. 
Tran et al. reported that IFNγ shapes the immune invasion of the CNS via 
regulation of chemokines (Tran et al., 2000). They found that IFNγ deficiency in 
mouse strains normally resistant to MBP-induced EAE renders them susceptible 
to disease induction and results in development of rapidly progressing lethal 
disease. They report widespread demyelination and disseminated leukocytic 
infiltration of the spinal cord and infiltrates dominated by Gr1+ neutrophils. They 
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found no expression of RANTES and MCP-1 but instead they reported elevated 
levels of MIP-2 and TCA-3. Lymph node cells from IFNγ-deficient mice 
proliferated in response to MBP, whereas the ones from IFNγ-sufficient mice did 
not. Overall, they conclude that IFNγ exerts a regulatory role in EAE, acting on 
proliferation of T cells and directing chemokine production. Our data shows that 
in mice normally conducive to active EAE induction there is no requirement for 
an increased CD4 T cell proliferation in atypical EAE resulting from disruption of 
IFNγ signaling. The implied role of chemokines in regulating the composition of 
immune cells is plausible and has been also suggested by others (Abromson-
Leeman et al., 2004). However, given that we have disrupted IFNγ signaling in 
almost every cell type present at the site of inflammation without inducing 
atypical EAE, it is unclear which cell type would be the source of the particular 
chemokines that are upregulated as a consequence of the absence of IFNγ. In 
accordance to our findings, neutrophils might play this role, since they have been 
shown to both produce and respond to MIP-2 (Scapini et al., 2000).  
Similar findings were reported by Krakowski et al., by using another 
strain resistant to MBP-induced EAE, namely BALB/c mice, and showed that 
targeted disruption of the IFNγ gene (GKO mice) converted them to a susceptible 
phenotype with as many as 17 out of 24 of IFNγ-deficient mice developing EAE, 
compared to mere 1 out of 16 in case of IFNγ-sufficient mice. They found 
meningeal and perivascular infiltrates in both spinal cord and brain, and have 
not reported any excessive accumulation of neutrophils at the site of 
inflammation (Krakowski and Owens, 1996). 
Wensky et al. reported that the occurrence of atypical EAE depends solely 
on the capacity of CNS-invading T cells to produce IFNγ. They used a mouse 
strain that spontaneously develops a severe, nonclassical form of EAE with 100% 
incidence. The distinct clinical phenotype was marked initially by a slight head 
tilt, progressing to a severe head tilt, spinning, or a rotatory motion. Classical 
EAE spontaneously occurred in MBP-specific TCR transgenic RAG-1-/- mice 
(referred to as T/R-), whereas nonclassical EAE spontaneously occurred in T/R- 
IFNγ-/- (T/R-γ-). Thus, the TCR recognized the same Ag (MBP) in both cases. The 
cellular infiltrates in nonclassical EAE were predominantly found in the 
brainstem and cerebellum, with very little inflammation in the spinal cord, which 
was in turn primarily affected in classical disease. Importantly, they also showed 
that, depending on the genetic makeup and priming conditions of the MBP-
specific T cells, nonclassical disease can occur in the presence of an inflammatory 
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infiltrate with eosinophilic, neutrophilic, or monocytic characteristics (Wensky et 
al., 2005). In principle, their work also supports the notion that neutrophil-rich 
immune cell infiltrates are not necessary for the occurrence of atypical EAE. They 
speculate that T cells that cause atypical disease potentially express a different 
chemokine repertoire that allows for their preferential recruitment to a specific 
site of the CNS. 
Stromnes et al. also report that the TCR specificity and cytokine repertoire 
of CD4 T cells are the main determinants of the type of EAE induced. They 
showed that the initiating events in both types of EAE are the same but the 
effector profile of the CD4 T cells effectually influences whether the brain or the 
spinal cord develop more severe inflammation. Although they put a strong 
emphasis on the nature of CD4 T cells, they show that the invaded tissue 
produces large amounts of IL17A and that neutralization of IL17A abolishes the 
capacity of CD4 T cells to invade the brain parenchyma specifically. With regards 
to the genes showing disproportionate increase in expression specifically in 
atypical EAE brains an upregulation consistent with enhanced local production 
of IL17A was revealed (Stromnes et al., 2008). Although this group makes a 
strong argument, our data shows that IL17A dependency is not unique across 
multiple strains, as Stromnes et al. used C3H mice in their studies. Our findings 
also in general reduce the importance of the cytokines produced by CD4 T cells 
as a determining factor for the outcome of EAE. Instead, it is more likely the 
tissue response to these cytokines that plays a decisive role and it is conceivable 
that various molecular stimuli (or lack thereof) could trigger the same or similar 
tissue response in terms of production of particular inflammatory intermediates. 
We think that this distinction, although minor, is relevant since Stromnes et al. 
speculated about the clinical relevance of their findings and the apparent role 
IL17A plays. Our results would clearly suggest otherwise. 
When discussing potential mechanisms of action, it is worthy to mention 
the study of Rose et al., who reported an augmentation of EAE when a 
monoclonal antibody to ICAM-1 was administered after adoptive transfer of 
encephalitogenic cells. The clinical disease was more severe in the anti-ICAM-1 
treated EAE mice and included prominent ataxia compared to the PBS-treated 
controls. Neuropathological evaluation demonstrated a distinct distribution of 
lesions in the anti-ICAM-1-treated mice which featured prominent demyelination 
and inflammation of the cerebellum, brainstem and cerebrum. These structures 
were minimally involved in the control mice (Rose et al., 1999). This report 
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emphasizes two important concepts. Rose et al. do not report extensive 
neutrophil infiltration of the inflamed CNS. Instead, they show immune 
infiltrates dominated by T cells. Their findings suggest once more that excessive 
neutrophilia is not required for the occurrence of atypical EAE. Additionally, 
they show that blockade of ICAM-1 is sufficient to induce atypical EAE. ICAM-1 
is expressed by endothelial cells and APCs. While it has been shown that 
multiple cytokines can upregulate ICAM-1 on endothelial cells in vitro (IL-1, 
TNFα, IFNγ), Koide et al. reported that neutralization of IFNγ completely 
inhibits ICAM-1 expression on vascular endothelial cells following injection of 
LPS in vivo (Koide et al., 1997). This provides a link to our work, allowing to 
suggest a potential explanation of the mechanism. Unresponsiveness to IFNγ 
could lead to the absence of ICAM-1 upregulation which, in turn, could result in 
atypical EAE. However, assuming that IFNγ indeed is absolutely required for 
upregulation of ICAM-1 on vascular endothelium (Boehm et al., 1997), we have 
shown that targeted disruption of IFNγ signaling on endothelial cells is 
insufficient to drive atypical EAE, suggesting that blocking ICAM-1 and probably 
also expression of a few other adhesion molecules is not a mechanism of action 
allowing atypical EAE in our experimental system. Another cell type known to 
express ICAM-1 are APCs. It would be interesting to investigate whether 
disruption of IFNγ signaling in subset of myeloid cells in the LysM-Cre x Ifngr2 
flox mice used in our work interferes with ICAM-1 expression and plays a role in 
the occurrence of atypical EAE. Additionally, the finding that IFNγ signaling on 
vascular endothelium is dispensable for efficient extravasation of leukocytes into 
the inflamed CNS presents an interesting starting observation for additional 
investigation. 
Willenborg et al. reported that 129/Sv mice, normally resistant to the 
induction of EAE with MOG, become susceptible upon deletion of the gene 
coding for the ligand-binding chain of the IFNγ receptor (Ifngr1, IFNGR1-KO 
mice). These mice develop EAE with high morbidity and mortality. Importantly, 
splenocytes from sensitized IFNGRl-KO mice proliferated extensively when 
stimulated with MOG peptide in culture and produced high levels of IFNγ. In 
both active and passive EAE there was an extensive involvement of neutrophils 
in the CNS lesions of IFNGR1-KO mice. (Willenborg et al., 1996). A few 
important points need to be re-emphasized from their work. They neither report 
atypical EAE nor mention disease signs that we now routinely classify as atypical 
EAE. The inability to sense IFNγ translates into more severe EAE and extensive 
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neutrophil infiltration of the CNS. Splenocytes deficient in IFNγ receptor still 
produced high levels of IFNγ upon MOG stimulation in vitro. In principle, the 
work from Willenborg et al confirms once more that neutrophil-rich infiltrates in 
the CNS do not necessarily induce atypical EAE. However, neutrophilia seems to 
be a consistent companion of EAE in IFNGR1-KO mice, which perfectly matches 
our findings in IFNGR1-KO mice. They also clearly reveal a point which we 
believe is a mistaken argument that compounds a unified interpretation of some 
work in the field of atypical EAE: A lot of emphasis has been put on the ability of 
CD4 T cells to produce IFNγ. However, given the fact that CD4 T cells are the 
main producers of IFNγ during EAE, it seems obvious that their inability to 
produce IFNγ most likely means that there is less IFNγ in the whole system. This 
implies that inability of CD4 T cells to produce IFNγ is somewhat equivalent to 
the inability of target tissues or cells to sense the cytokine - simply because there 
is not sufficient amount around. 
This concept was also supported by the work of Lees et al., who showed, 
by using an adoptive transfer system, that the ability of the CNS to sense 
pathogenic T cell-derived IFNγ during EAE initiation determines the sites of 
CNS pathogenesis. Transfer of WT Th1 cells into IFNγ receptor-deficient mice 
resulted in pathogenic invasion of the brain stem and cerebellum with clinical 
symptoms of atypical EAE, which were identical to the disease observed after 
transfer of IFNγ-deficient T cells to WT hosts. Inflammation of the spinal cord 
associated with classical EAE was abrogated in both IFNγ-deficient systems. 
Cotransfer of CNS antigen-specific WT Th1 cells with IFNγ-deficient T cells was 
sufficient to restore spinal cord invasion and block cerebellar and brain stem 
invasion (Lees et al., 2008). Their data demonstrates that IFNγ interacts with 
either the CNS cells or other non-T cells capable of sensing IFNγ during the 
initiation phase of EAE and that the this interaction likely influences the 
subsequent steps of neuroinflammation and pathogenesis.  
Abromson-Leeman et al. reported two distinct clinical phenotypes of EAE 
in BALB/c GKO mice immunized with encephalitogenic peptides of MBP. 
Conventional disease, characterized by ascending weakness and paralysis, 
occurred with greater frequency after immunizing with a peptide comprising 
MBP residues 59 to 76. Axial-rotatory disease, characterized by uncontrolled axial 
rotation, occurred with greater frequency in mice immunized with a peptide 
corresponding to exon 2 of the full length 21.5-kDa protein. The conventional 
disease was characterized by inflammation and demyelination primarily in 
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spinal cord, whereas axial-rotatory disease involved inflammation and 
demyelination of lateral medullary areas of brain. Both types had infiltrates in 
which neutrophils were a predominating component. By isolating T cells and 
transferring the disease to naive recipients, they showed that the type of disease 
was determined entirely by the nature of inducing T cell type. Most intriguingly, 
they showed, using CXCR2 knockout recipients which are unable to recruit 
neutrophils to inflammatory sites, that among the two different cell lines derived 
from GKO mice, one was critically dependant on neutrophils to effect the disease 
(3A clone) while the other was not (X2.502 clone) (Abromson-Leeman et al., 
2004). In a continuation of their work, they showed that neither of the two GKO-
derived cell lines (now with slightly different nomenclature suggestive of 
derivatives/subclones of the original 3A and X2.502 clones) relied on IL17A to 
effect the disease (Abromson-Leeman et al., 2007). The authors once more show 
that composition of cells infiltrating the CNS in atypical EAE is not a determinant 
of ensuing clinical features. Also, they report an interesting observation, where 
an encephalitogenic T cell clone shows upregulation of a set of genes normally 
associated with Th17 effector phenotype but does not depend on IL17A itself to 
realize its encephalitogenic potential. This observation could, at least in theory, 
explain why we see no dependence on IL17A, while Th17 effector cells have been 
shown to be indispensable in some previous reports. Nevertheless, Stromnes et 
al. have clearly shown dependency of atypical EAE on IL17A, while Kroenke et 
al. reported dependency on IL17RA. To explain the difference between IL17A 
and IL17RA dependency is rather straightforward based on existing knowledge, 
since the IL17RA is needed for both IL17A and IL17F signaling. Thus, the 
relevant cytokine might be IL17F. So far we have not explicitly examined the 
potential role of IL17F in our experimental system. Also, we have not recognized 
the unifying aspect of our work and the work of Stromnes et al. in terms of IL17A 
relevance, if one exists at all. Unfortunately, the difference between our and their 
experimental setup is rather significant (passive EAE in C3H mice vs. active EAE 
in C57Bl/6) and this, unfortunately, might just be enough to not allow a direct 
comparison of conclusions. Hopefully, the continuation of our work might reveal 
some additional relevant comparison points. 
In summary, taking into account all the correlated and non-correlated 
findings discussed so far, it is very likely that atypical EAE, as it is defined at the 
moment, is only an observable manifestation of multiple different 
neuroinflammatory pathways that preferentially inflict tissue damage to the 
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brain stem and cerebellum, rather than the spinal cord. The underlying 
mechanism of action is most probably not the same in all the different models 
presented. Despite that, they are all valuable tools to study a "different kind" of 
neuroimmune inflammation in rodents and provide a chance to gain additional 
insight into the immune mechanisms in effect during autoimmune inflammation 
of the CNS. 
Conclusion and future work 
Our work shows that disrupted IFNγ signaling in neutrophils and a 
subset of myeloid cells is sufficient to drive atypical EAE. The composition of the 
immune cells infiltrating the CNS is not a determinant of the ensuing clinical 
manifestation of EAE. The atypical EAE in the context of IFNγ deficiency is not 
dependent on IL17A nor is mediated by disrupted IFNγ signaling in microglia, as 
was suggested by some authors. Furthermore, absence of IFNγ signaling on 
vascular endothelium and presumed changes in the expression pattern of its 
adhesion molecules that result from it have no impact on the capacity of 
circulating leukocytes to extravasate and reach the CNS during 
neuroinflammation. Additionally, we were able to show that inability of CNS 
tissue to respond to IFNγ stimulation during neuroinflammation does not 
noticeably influence the extent of tissue damage inflicted by the infiltrating 
immune cells. 
The finding that the mouse strain with disrupted IFNγ signaling in cells 
that have activated the lysozyme M promoter does not allow for a precise 
conclusion on which cell type plays a critical role in allowing for the occurrence 
of atypical EAE since multiple different cell types are affected - neutrophils and 
moDCs being the most notable ones. To address this in greater detail, we plan to 
deplete neutrophils from peripheral blood of IFNγR-deficient mice and 
adoptively transfer WT T cells from a mouse previously immunized with MOG35-
55 in CFA. This adoptive transfer experiment would allow us to judge the 
requirement for neutrophils during adoptive transfer EAE. The possibility to 
induce atypical EAE in the mentioned experimental setup would suggest that 
moDCs play a crucial role in allowing for the occurrence of atypical EAE.  
Additionally, crossing the Ifngr2tm1Hzi mouse strain to CCR2-CreERt2 
mouse strain would hopefully allow us to disrupt the IFNγ signaling in moDCs. 
Observing the clinical signs of EAE in this newly created strain will allow us to 
draw additional conclusions on the role of moDCs during atypical EAE and 
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show which cell type most likely plays a crucial role in allowing for the 
occurrence of atypical EAE. 
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